{"study_id": 33229, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the main components of ethanol extract of propolis (EEP) and its antitumor mechanism against skin squamous cell carcinoma A431 cells.", "results_summary": "The study identified 43 polyphenolic components in EEP and 1052 metabolites, with significant upregulation (160) and downregulation (143) in treated cells. EEP inhibited A431 cell proliferation via steroid hormone biosynthesis and linoleic acid metabolism pathways.", "population_specificity": "Skin squamous cell carcinoma A431 cells (in vitro study).", "effective_dosage": "IC50 of 29.04 \u03bcg/mL EEP.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.384865+00:00"}
{"study_id": 33230, "supplement_id": 1477, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of propolis on gut microbiota and uremic toxin levels in hemodialysis patients with chronic kidney disease.", "results_summary": "Propolis supplementation did not significantly reduce plasma levels of uremic toxins (IAA, IS, p-CS) or alter fecal microbiota composition, though microbial evenness and richness showed non-significant increases.", "population_specificity": "42 hemodialysis patients with chronic kidney disease (41 completed the study).", "effective_dosage": "400 mg of green propolis extract per day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.990657+00:00"}
{"study_id": 33231, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the wound-healing effects of a propolis-based cream derived from Amazon stingless bees on induced wounds in rats.", "results_summary": "The propolis-based cream (PR) showed comparable wound diameter reduction to collagenase (PC) but exhibited a milder inflammatory response and directly influenced lesion maturation, likely due to its antimicrobial and anti-inflammatory compounds.", "population_specificity": "14 Wistar rats divided into three treatment groups.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:33.572310+00:00"}
{"study_id": 33232, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of a combination of Lepidium sativum mucilage (LS) coating and propolis extract (PE) on prolonging the shelf life of buffalo meat.", "results_summary": "The study found that PE, combined with LS, significantly inhibited microbial growth and preserved meat quality, with the 2.5% PE concentration being most effective. Sensory evaluation indicated a three-day extension in shelf life.", "population_specificity": "Buffalo meat samples stored at 4\u00b0C.", "effective_dosage": "0.5%, 1.5%, and 2.5% PE concentrations in the coating mixture.", "study_duration": "9 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:36.791241+00:00"}
{"study_id": 33234, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of ethanolic extract of propolis in alleviating secondary liver, renal, and pancreatic lesions caused by colorectal cancer, comparing its effects to vitamin E.", "results_summary": "Ethanolic extract of propolis significantly reduced liver damage markers (alanine transaminase), lowered uric acid, increased pancreatic insulin, and reduced inflammation and cell necrosis in liver, kidney, and pancreas tissues compared to the dimethylhydrazine group. It demonstrated antioxidant, anticancer, and anti-inflammatory potential.", "population_specificity": "Rats with colorectal cancer-induced secondary lesions.", "effective_dosage": "Not specified", "study_duration": "13 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:37.777282+00:00"}
{"study_id": 33233, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers sought to determine the effects of Thai propolis extract mixed with mineral trioxide aggregate (MTA) on MMP-2 expression and activity in inflamed human dental pulp cells (HDPCs).", "results_summary": "Propolis extract at 0.75 mg/ml, alone or mixed with MTA, reduced MMP-2 expression and activity in inflamed HDPCs compared to MTA mixed with distilled water. Chlorhexidine also significantly inhibited MMP-2, while Dycal\u00ae increased cell death and reduced MMP-2.", "population_specificity": "Inflamed human dental pulp cells (HDPCs)", "effective_dosage": "0.75 mg/ml propolis extract", "study_duration": "24 or 72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:37.779847+00:00"}
{"study_id": 33235, "supplement_id": 1477, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a propolis-mangosteen extract complex (PMEC) in improving gingival health by reducing inflammatory biomarkers in patients with gingivitis and incipient periodontitis.", "results_summary": "PMEC significantly reduced inflammatory biomarkers (IL-1\u03b2, PGE2, MMP-8, MMP-9) compared to placebo (p < 0.0001), but clinical parameter improvements were not statistically significant. No significant adverse events were reported.", "population_specificity": "104 subjects with gingivitis and incipient periodontitis.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:38.671299+00:00"}
{"study_id": 33236, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether propolis nanoemulsions (PNEs) could effectively modulate gut microbiota and metabolites to treat osteoporosis via the gut-bone axis.", "results_summary": "Orally administered PNEs showed superior antiosteoporosis effects in an ovariectomized mouse model by altering gut microbiota structure, increasing l-arginine levels, restoring intestinal barrier function, and balancing bone remodeling by suppressing osteoclast activity and enhancing osteoblast function.", "population_specificity": "Ovariectomized (OVX) mice (a model for postmenopausal osteoporosis).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:39.280604+00:00"}
{"study_id": 33238, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of propolis supplementation on body composition (weight, BMI, WC, HC, WHR, FM) and blood pressure (SBP, DBP) in adults through a systematic review and dose-response meta-analysis of RCTs.", "results_summary": "Propolis supplementation significantly reduced weight and BMI but had no significant effects on WC, WHR, FM, HC, SBP, or DBP. The impact on BMI and WC plateaued after 8 weeks of intervention.", "population_specificity": "Adults (1082 participants across 22 RCTs)", "effective_dosage": "Not specified", "study_duration": "Up to 8 weeks (impact plateaued beyond this duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:41.767365+00:00"}
{"study_id": 33240, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-H. pylori activity of Brazilian red propolis (BRP), focusing on its ability to inhibit biofilm formation and eradicate existing biofilms.", "results_summary": "BRP demonstrated strong anti-H. pylori activity, eliminating all bacterial cells at 50 \u00b5g/mL in 24 hours and effectively inhibiting biofilm formation (MICB50 of 15.6 \u00b5g/mL) and eradicating biofilms (MBEC of 2000 \u00b5g/mL).", "population_specificity": "H. pylori (ATCC 43526) in vitro.", "effective_dosage": "15.6 \u00b5g/mL (MICB50), 50 \u00b5g/mL (time-kill), 500-2000 \u00b5g/mL (biofilm eradication).", "study_duration": "24 hours (time-kill), 72 hours (biofilm formation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:46.485515+00:00"}
{"study_id": 33242, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether propolis and its extracts could reduce the bioaccessibility and relative bioavailability of lead (Pb) and cadmium (Cd) in rice.", "results_summary": "Propolis and its extracts significantly reduced Pb bioaccessibility in both brown and polished rice. Mouse bioassays showed a notable decrease in Pb relative bioavailability, suggesting propolis may help mitigate heavy metal exposure.", "population_specificity": "Mice (in vivo) and in vitro tests (rice samples)", "effective_dosage": "Medium dose of proanthocyanidins (PA) was used; specific propolis dosage not detailed.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:47.757659+00:00"}
{"study_id": 33243, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a methodology for fractionating Brazilian green propolis hexane extract to isolate prenylated biomarkers and evaluate their potential to inhibit the interaction between the SARS-CoV-2 spike protein RBD and the ACE2 receptor.", "results_summary": "The study successfully isolated artepillin C and baccharin, which showed 67% and 51% inhibition of the RBD-ACE2 interaction at 10 \u03bcM, respectively. The fractionation technique was noted for its low operational cost and excellent reproducibility.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "10 \u03bcM concentration in the immunoassay", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:48.034246+00:00"}
{"study_id": 33241, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the chemical composition, antioxidant, and antimicrobial activity of Baltic region propolis extracts against various veterinary pathogens.", "results_summary": "The study found that propolis extracts exhibited antioxidant activity, with p-coumaric acid being the predominant phenolic compound. DES propolis extracts showed stronger antimicrobial activity compared to ethanolic extracts, with MIC values ranging between 50 and 1000 \u03bcg/mL against tested bacterial and fungal strains.", "population_specificity": "Veterinary pathogens (bacterial and fungal strains) collected from Lithuanian University of Health Sciences, Academy of Veterinary Medicine, and Institute of Microbiology and Virology.", "effective_dosage": "Not specified (MIC values ranged between 50 and 1000 \u03bcg/mL).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:48.411577+00:00"}
{"study_id": 33244, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to provide a mechanistic account of the anti-cancer effects of propolis and its components, focusing on its potential as an adjuvant therapy in cancer treatment.", "results_summary": "Propolis exhibits anti-cancer potential by modulating critical signaling pathways, preventing angiogenesis, counteracting metastatic progression, regulating cell cycle proteins, and inducing apoptosis. Its diverse bioactive compounds show promise in reducing side effects associated with conventional cancer therapies.", "population_specificity": "Not specified (general cancer treatment context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:48.445423+00:00"}
{"study_id": 33245, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of Propolis (PRO) in counteracting cadmium (Cd)-induced testicular dysfunction and infertility in rats.", "results_summary": "Propolis significantly protected against Cd-induced oxidative stress, inflammation, hormonal imbalances, and DNA damage, improving sperm quality and testicular structure. It also enhanced fertility indices compared to the Cd-exposed group.", "population_specificity": "Mature male Wistar albino rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:49.408265+00:00"}
{"study_id": 33251, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective role of propolis against streptozotocin-induced diabetic nephropathy in rats.", "results_summary": "Propolis partially restored normal lipid profiles, antioxidant biomarkers, and renal cortical morphology, demonstrating renoprotective effects through hypoglycemic, anti-hyperlipidemic, and antioxidant mechanisms.", "population_specificity": "Streptozotocin-induced diabetic rats", "effective_dosage": "300 mg/kg/day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:55.880201+00:00"}
{"study_id": 33239, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the chemical composition of propolis from different regions and assess its efficacy, alone and in combination with vitamin D, in inhibiting ovarian cancer cell viability and proliferation.", "results_summary": "Propolis extracts from France, Egypt, and Germany showed varying levels of activity in inhibiting ovarian cancer cell viability, with the French extract being the most effective. Combining propolis with vitamin D enhanced cell viability inhibition and reduced proliferative activity, particularly with the French propolis type.", "population_specificity": "Human ovarian cancer cells (OVCAR4) in vitro.", "effective_dosage": "Propolis concentrations (1-400 \u03bcg/mL); vitamin D (0.0015-0.15 \u03bcg/mL).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:56.765232+00:00"}
{"study_id": 33247, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether ethanolic extract of propolis (EEP) could alleviate lipid metabolism disorders and aging-related effects in high-fat diet-fed aging mice.", "results_summary": "EEP improved hair luster, reduced weight gain, lowered systemic inflammation, enhanced hepatic antioxidant activity, and improved lipid metabolism by activating the PPAR pathway and enhancing bile acid metabolism. It also reduced hepatic lipid deposition and inflammatory cell infiltration.", "population_specificity": "Senescence-accelerated mouse prone 8 (SAMP8) mice fed a high-fat diet.", "effective_dosage": "200 mg/kg body weight", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:56.852988+00:00"}
{"study_id": 33250, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether propolis supplementation could reduce serum levels of inflammatory markers (IL-6, CRP, and TNF-\u03b1) through a systematic review and meta-analysis.", "results_summary": "Propolis significantly reduced serum levels of IL-6, CRP, and TNF-\u03b1, with geographical region and dosage being critical factors for beneficial effects.", "population_specificity": "Not specified (meta-analysis of multiple studies).", "effective_dosage": "Not specified (varies by included studies).", "study_duration": "Not specified (varies by included studies).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:57.111585+00:00"}
{"study_id": 33246, "supplement_id": 1477, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the association of red propolis (RP) and platelet-rich plasma (PRP) as inducers of adipose-derived stromal cells (ADSC) for tissue regeneration.", "results_summary": "RP extracts up to 50 \u03bcg.mL-1 showed no cytotoxic effects and, when combined with PRP at 25 and 50 \u03bcg.mL-1, enhanced ADSC migration, achieving total wound closure by the seventh day. The results suggest RP may stimulate ADSC proliferation, aiding tissue regeneration.", "population_specificity": "Adipose-derived stromal cells (ADSC) in vitro.", "effective_dosage": "25 and 50 \u03bcg.mL-1 of RP.", "study_duration": "Seven days post-exposition.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:57.372624+00:00"}
{"study_id": 33248, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential efficacy of propolis against atopic dermatitis (AD) and identify its active compound and molecular target.", "results_summary": "Propolis inhibited inflammatory markers (IL-6, IL-8, MCP-1, MDC) and restored skin barrier proteins (filaggrin, involucrin) in human keratinocytes and AD-like skin. In mice, oral propolis reduced AD symptoms, improved barrier function, and decreased scratching frequency and transepidermal water loss, with caffeic acid phenethyl ester (CAPE) identified as the active compound targeting MKK4.", "population_specificity": "HaCaT keratinocytes, AD-like human skin, and DNCB-induced mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:58.693209+00:00"}
{"study_id": 33252, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a novel gingival retraction cord (P/TA@CSy) loaded with Propolis and tranexamic acid for hemostasis, infection prevention, and anti-inflammatory properties in dental treatment.", "results_summary": "P/TA@CSy demonstrated excellent antibacterial activity (94.73-99.99% against tested bacteria), rapid coagulation (456 s), suppression of pro-inflammatory cytokines (IL-6 and TNF-\u03b1), and 100% cell viability after 24 hours.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "24-hour cytocompatibility assessment mentioned; full duration not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:59.074527+00:00"}
{"study_id": 33237, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of 5% Brazilian green propolis ointment in treating chronic ulcers compared to essential fatty acid treatment.", "results_summary": "The study found that both treatments had an effect, but the propolis group showed greater effectiveness in improving ulcer tissue characteristics, exudate, edge features, microbial content, and pain reduction.", "population_specificity": "40 patients with chronic ulcers, randomized equally into control and experimental groups.", "effective_dosage": "5% green propolis ointment (frequency not specified).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:02.825304+00:00"}
{"study_id": 33253, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the potential of East Kalimantan propolis from Trigona apicalis for breast cancer treatment, focusing on its bioactive compounds and underlying mechanisms.", "results_summary": "The study identified eight propolis compounds with anti-breast cancer activity, particularly targeting MMP9, and demonstrated that chrysin and quercetin had strong binding affinity and stability comparable to the control drug marimastat.", "population_specificity": "Breast cancer (in vitro and bioinformatics analysis)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:04.212374+00:00"}
{"study_id": 33256, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of a propolis-containing toothpaste on salivary biomarkers and plaque index compared to a standard fluoridated toothpaste.", "results_summary": "The study found no significant changes in salivary proteins, pH, or amylase activity in either group. However, the propolis group showed a superior decline in plaque index and a significant decrease in IL-10 levels compared to the control group.", "population_specificity": "76 participants from a municipality without fluoridated public water.", "effective_dosage": "Not specified (toothpaste used 3 times daily for 2 minutes each).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:06.292189+00:00"}
{"study_id": 33254, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of an ethanolic extract of Spanish propolis (EESP) as an inhibitor of adhesion and biofilm formation by Staphylococcus epidermidis.", "results_summary": "EESP significantly delayed bacterial growth, homogenized surface properties, and reduced adherence and biofilm formation by up to 90.5%. Microscopic analysis showed that surviving planktonic cells were responsible for surface adherence.", "population_specificity": "Staphylococcus epidermidis strains with varying biofilm-forming capacities.", "effective_dosage": "Sub-inhibitory concentrations (sub-MICs) of EESP (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:06.554234+00:00"}
{"study_id": 33255, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the antioxidant properties of Chinese propolis (CP) and poplar bud extract (PBE) and elucidate their underlying mechanisms.", "results_summary": "Both CP and PBE exhibited strong antioxidant activity, reduced oxidative stress markers (ROS, MDA), enhanced antioxidant enzyme activity (SOD, CAT), and upregulated key genes (daf-16, sod-3, hsp-16.2, skn-1) in C. elegans, suggesting their potential for treating oxidative damage-related diseases.", "population_specificity": "C. elegans (nematodes)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:06.819961+00:00"}
{"study_id": 33257, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the stability of phenolic compounds (flavonoids and phenolic acids) in propolis extracts obtained using different extraction methods and parameters.", "results_summary": "The study found that benzoic acid and chlorogenic acid derivatives were highly stable across ultrasound extraction procedures, while flavonoid recoveries varied, with luteolin, quercitrin, and hesperetin being the most stable. Neutral pH improved flavonoid recovery, whereas phenolic acids remained more stable at pH 2, and 15 minutes of ultrasound extraction yielded the best recoveries for most phenols.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:08.012795+00:00"}
{"study_id": 33258, "supplement_id": 1477, "safety_score": "100", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of a dietary supplement containing propolis (DSHPP) as an adjuvant treatment for acute tonsillopharyngitis in children, to reduce inappropriate antibiotic use.", "results_summary": "DSHPP + standard of care (SoC) outperformed SoC alone in reducing throat pain, erythema, and swallowing difficulty, with significant improvements in the total tonsillitis severity score. No adverse events were reported, and only one treatment failure occurred in the SoC group.", "population_specificity": "Children aged 3-10 years with acute tonsillopharyngitis of \u226448 hours duration and negative for beta-hemolytic Streptococcus.", "effective_dosage": "Not specified", "study_duration": "6 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:09.226451+00:00"}
{"study_id": 33259, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential neuroprotective effects of Propolis from Geniotrigona thoracica as an adjunctive therapy for cerebral edema following intracerebral hemorrhage (ICH) in rats.", "results_summary": "Propolis treatments (propolis-A and propolis-B+A) improved neurocognitive functions, reduced cerebral edema, and lowered levels of injury markers (NF-\u03baB, SUR1-TRPM4, MMP-9, Aquaporin-4). Combining propolis with mannitol (propolis-M) further enhanced these effects.", "population_specificity": "Sprague Dawley rats with induced intracerebral hemorrhage (ICH).", "effective_dosage": "Not specified (daily oral administration).", "study_duration": "7 days prior to and 72 hours after ICH induction for propolis-B+A; duration for other groups not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:09.551236+00:00"}
{"study_id": 33260, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the anti-inflammatory effects of ethanol extract from poplar propolis (EEP) and poplar tree gum (EEG) against MRSA-induced acute lung injury (ALI) in mice and assess their impact on gut microbiota and serum metabolites.", "results_summary": "Pre-treatment with EEP and EEG (100 mg/kg) significantly protected against ALI in mice, with EEP showing stronger effects in reducing lung tissue lesions and inflammatory mediators (TNF-\u03b1, IL-1\u03b2, IL-6, IFN-\u03b3). Both modulated gut microbiota, increased beneficial bacteria, and partly restored short-chain fatty acids, with EEP showing a stronger correlation between serum metabolites and gut microbiota.", "population_specificity": "Mice with MRSA-induced acute lung injury", "effective_dosage": "100 mg/kg, orally", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:13.590716+00:00"}
{"study_id": 33262, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze pharmaceutical patents containing green propolis to understand its diverse pharmacological applications and formulations.", "results_summary": "The study identified 22 patents demonstrating green propolis's pharmacological activities, including cancer treatment, food supplements, and innovations for controlled release. Most patents focused on formulation preparation, extraction methods, and systemic or topical use.", "population_specificity": "Not specified (patent analysis)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:14.402236+00:00"}
{"study_id": 33261, "supplement_id": 1477, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop natural, biocompatible nanofibers from royal jelly and propolis to treat cutaneous leishmaniasis with minimal side effects.", "results_summary": "The study found that propolis nanofibers significantly inhibited the growth of Leishmania major in vitro with negligible cytotoxicity on host cells. The nanofibers showed promising killing activity while being biocompatible and low-cost.", "population_specificity": "In vitro study (Leishmania major and host cells).", "effective_dosage": "Not specified (IC50 and EC50 values provided for nanofibers).", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:14.623653+00:00"}
{"study_id": 33265, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of propolis and Gluma desensitisers in managing dentin hypersensitivity.", "results_summary": "Propolis significantly reduced dentin hypersensitivity immediately after application, but its effectiveness decreased after one month compared to Gluma. Both agents were effective initially, but Gluma showed better long-term results.", "population_specificity": "Patients with dentin hypersensitivity (22 patients, 80 teeth) at a dental institute in Karachi.", "effective_dosage": "Not specified", "study_duration": "One month follow-up after intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:15.154860+00:00"}
{"study_id": 33264, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize and characterize a polyacrylamide/methylcellulose hydrogel containing propolis as an active ingredient for use as a wound dressing to treat skin lesions.", "results_summary": "The hydrogels exhibited a porous structure, good water absorption, desirable mechanical properties, and strong antioxidant activity, with higher propolis concentrations showing increased polyphenol and flavonoid content.", "population_specificity": "In vitro testing on Vero cells and J774 macrophages.", "effective_dosage": "1.0% and 2.5% propolis in hydrogels.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:17.152010+00:00"}
{"study_id": 33266, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to critically appraise the clinical applications of propolis-based compounds in endodontic therapy for primary and permanent teeth, focusing on its antimicrobial, anti-inflammatory, immunomodulatory, and wound-healing properties.", "results_summary": "Propolis showed promising outcomes in controlling inflammation, enhancing tissue repair, and disinfecting the root canal system, but methodological flaws in the studies limited the reliability of these conclusions.", "population_specificity": "Patients undergoing endodontic therapy for primary and permanent teeth.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:17.434800+00:00"}
{"study_id": 33267, "supplement_id": 1477, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to chemically profile propolis and evaluate its antibacterial, antioxidant, anti-inflammatory, and burn-healing properties in vitro and in vivo.", "results_summary": "Propolis exhibited significant antibacterial activity, antioxidant effects (IC50 values of 46.52\u00b11.25 and 11.74\u00b10.26 \u03bcg/mL), and anti-inflammatory properties by downregulating TLR4, IL-6, and TNF-\u03b1. It also promoted burn healing in vivo without skin irritation or sensitization.", "population_specificity": "Infected burn wound mice model and rabbits/guinea pigs for safety assessment.", "effective_dosage": "Not specified (concentration-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:18.923754+00:00"}
{"study_id": 33268, "supplement_id": 1477, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prophylactic effects of standardized propolis extract (EPP-AF\u00ae) on sepsis survival and lung preservation in mice.", "results_summary": "Prophylactic treatment with EPP-AF\u00ae significantly increased the lifespan of septic mice and reduced lung tissue damage, though it did not affect bacterial colony counts or systemic coagulation parameters.", "population_specificity": "Swiss mice subjected to sepsis via cecal ligation and puncture (CLP).", "effective_dosage": "10 mg/kg and 100 mg/kg, administered subcutaneously once 6 hours before CLP.", "study_duration": "Single dose administered 6 hours pre-CLP, with survival monitored for 5 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.144537+00:00"}
{"study_id": 196246, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether propolis supplementation could improve clinical symptoms in women with uncomplicated cystitis when used alongside ciprofloxacin.", "results_summary": "Propolis supplementation significantly reduced urinary frequency, dysuria, and urgency compared to placebo, but showed no significant effect on hematuria or suprapubic pain. Bacteriuria severity decreased in both groups.", "population_specificity": "120 women with uncomplicated cystitis", "effective_dosage": "Two 500 mg capsules of propolis daily", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:22.865078+00:00"}
{"study_id": 33269, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the cytotoxic effects and mechanisms of action of mangiferolic acid (MF) from Tetragonula laeviceps propolis against KATO-III gastric cancer cells.", "results_summary": "MF exhibited strong cytotoxicity against KATO-III cells, inducing late apoptosis and necrosis, potentially mediated by upregulated inflammation-related genes (COX2, NF\u03baB, CASP3, CASP7). The effects were dose- and time-dependent, with significant results at 48 and 72 hours.", "population_specificity": "KATO-III gastric cancer cells (in vitro study).", "effective_dosage": "30 \u03bcg/mL of MF.", "study_duration": "Up to 72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:22.916492+00:00"}
{"study_id": 196245, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of propolis consumption on glycemic indices and liver enzymes in adults through a systematic review and meta-analysis of RCTs.", "results_summary": "Propolis consumption significantly reduced fasting blood glucose, insulin, glycosylated hemoglobin, homeostatic model assessment of insulin resistance, alanine transaminase, and aspartate aminotransferase, but had no significant effect on gamma-glutamyl transferase.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:23.056223+00:00"}
{"study_id": 33271, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the phenolic compounds in Siirt propolis extracts and investigate their antidiabetic and antioxidant activities.", "results_summary": "Propolis extracts showed moderate antioxidant activity (13.86%-35.72% for DPPH and 33.62%-62.50% for ABTS at 30 \u03bcg mL-1) and high inhibitory effects against \u03b1-glucosidase (IC50 of 5.72 \u00b1 0.83 \u03bcg mL-1), suggesting potential benefits for diabetes and oxidative stress.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "30 \u03bcg mL-1 (test concentration)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:24.145564+00:00"}
{"study_id": 196248, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of propolis on metabolic factors, high-sensitivity C-reactive protein, and testosterone in women with PCOS.", "results_summary": "Propolis supplementation significantly reduced hip circumference, fasting insulin, insulin resistance, testosterone, and LDL/HDL ratio in PCOS women compared to placebo. While fasting blood glucose initially decreased, significance was lost after adjusting for confounders.", "population_specificity": "Women with polycystic ovarian syndrome (PCOS)", "effective_dosage": "500 mg propolis/day (two tablets/day)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:25.243863+00:00"}
{"study_id": 196247, "supplement_id": 1477, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of standardized Brazilian green propolis extract (EPP-AF\u00ae) on hospitalized COVID-19 patients during the third wave of the pandemic, focusing on length of hospital stay and secondary outcomes like safety and infection rates.", "results_summary": "Propolis did not significantly reduce hospital stay or oxygen dependency but was associated with a lower incidence of secondary infections (6.1% vs. 18.9% in the placebo group) and was deemed safe for use.", "population_specificity": "Hospitalized adult COVID-19 patients.", "effective_dosage": "900 mg/day orally.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:25.822302+00:00"}
{"study_id": 196249, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis.", "results_summary": "Propolis supplementation significantly reduced atherogenic indices, hs-CRP levels, and marginally reduced MCP-1, indicating potential benefits for cardiovascular health in rheumatoid arthritis patients.", "population_specificity": "Women diagnosed with rheumatoid arthritis (48 patients).", "effective_dosage": "1000 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:26.246407+00:00"}
{"study_id": 196250, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether propolis, alone or combined with exercise, could improve dyslipidemia and related biomarkers in women with type 2 diabetes.", "results_summary": "The study found that combining propolis supplementation with exercise improved lipid profiles, reduced inflammation (IL6, MDA), and enhanced antioxidant defense (TAC, SOD) in diabetic women with dyslipidemia. The EXR+SUPP group showed the most significant improvements compared to other groups.", "population_specificity": "60 women with type 2 diabetes and dyslipidemia", "effective_dosage": "500 mg propolis capsules", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:28.801981+00:00"}
{"study_id": 196253, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Brazilian propolis on body fat mass, adiponectin levels, and reactive oxygen species in elderly females.", "results_summary": "The study was a double-blind randomized placebo-controlled trial, but the abstract does not provide specific results regarding the effects of propolis on the measured outcomes.", "population_specificity": "Community-dwelling elderly females aged 66-84 years.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:30.332071+00:00"}
{"study_id": 196252, "supplement_id": 1477, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of Iranian propolis on indicators of metabolic syndrome (MeS), quality of life, and mood status in individuals with MeS.", "results_summary": "Propolis supplementation significantly reduced waist circumference and improved physical functioning, general health, and overall quality of life scores compared to placebo, but had no significant effects on other anthropometric or biochemical parameters.", "population_specificity": "66 eligible patients with metabolic syndrome.", "effective_dosage": "250 mg of propolis extract, twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:31.095262+00:00"}
{"study_id": 196251, "supplement_id": 1477, "safety_score": "90", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of propolis on kidney function parameters, pro-oxidant-antioxidant balance, glycemic status, quality of life, and blood pressure in patients with chronic kidney disease (CKD).", "results_summary": "Propolis supplementation significantly improved some dimensions of health-related quality of life in CKD patients but did not significantly affect kidney function parameters, glycemic status, blood pressure, or pro-oxidant-antioxidant balance compared to placebo. No serious adverse events were reported.", "population_specificity": "44 patients with chronic kidney disease (35 completed the trial).", "effective_dosage": "250 mg daily", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:31.640052+00:00"}
{"study_id": 196254, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of propolis supplementation on glucose homeostasis, lipid profile, liver function, anthropometric indices, and meta-inflammation in patients with NAFLD.", "results_summary": "The study evaluated propolis in a double-blind placebo-controlled trial, but the abstract does not specify the outcomes or results of the intervention.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD) confirmed by ultrasonography.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:31.843741+00:00"}
{"study_id": 196256, "supplement_id": 1477, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether propolis, as an adjunct therapy, could reduce the negative effects of COVID-19, particularly in shortening hospital stays and improving clinical outcomes.", "results_summary": "Propolis supplementation (400 mg/day and 800 mg/day) significantly reduced hospital stay duration compared to standard care alone. The higher dose also reduced acute kidney injury rates, but it did not significantly affect oxygen supplementation needs.", "population_specificity": "Hospitalized adult COVID-19 patients.", "effective_dosage": "400 mg/day and 800 mg/day orally.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:33.840943+00:00"}
{"study_id": 196257, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of propolis supplementation on clinical symptoms in patients with COVID-19.", "results_summary": "The abstract does not provide results on the efficacy or safety of propolis, as it describes the study protocol rather than outcomes.", "population_specificity": "Patients aged 18-75 with confirmed COVID-19, excluding those with sensitivity to bee products or current use of warfarin/propolis supplements.", "effective_dosage": "300 mg Iranian green propolis extract tablet, three times daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:34.200526+00:00"}
{"study_id": 196255, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of propolis versus placebo on nutritional status and quality of life in breast cancer patients undergoing chemotherapy.", "results_summary": "The abstract does not provide specific results, but the study design suggests an investigation into propolis's potential benefits in mitigating chemotherapy-induced side effects.", "population_specificity": "60 breast cancer patients receiving chemotherapy at the Oncology Clinic at Tohid Hospital, Sanandaj, Iran.", "effective_dosage": "250 mg (frequency not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:34.265588+00:00"}
{"study_id": 196258, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of royal jelly (RJ) ingestion on glycemic markers compared to placebo, focusing on fasting plasma glucose (FPG) and HbA1c.", "results_summary": "The meta-analysis found that RJ consumption reduced FPG by 0.95 mg/dl, but the result was not statistically significant (p = 0.69). No significant effect on HbA1c was observed.", "population_specificity": "A total of 205 participants for FPG and 130 participants for HbA1c were included across 5 studies.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:37.698178+00:00"}
{"study_id": 196259, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of propolis supplementation on glycemic markers in adults with type 2 diabetes mellitus (T2DM).", "results_summary": "Propolis supplementation significantly reduced fasting plasma glucose and hemoglobin A1C levels but did not significantly affect fasting insulin levels or insulin resistance.", "population_specificity": "Adults with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:38.082997+00:00"}
{"study_id": 196260, "supplement_id": 1477, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of oral propolis supplementation on blood glucose, insulin resistance, and antioxidant status in patients with type 2 diabetes.", "results_summary": "Propolis supplementation improved glycemic status, reduced insulin resistance, and enhanced antioxidant status in type 2 diabetes patients, with no reported side effects.", "population_specificity": "62 patients with type 2 diabetes, aged 30-55 years.", "effective_dosage": "500 mg three times a day (total 1500 mg/day).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:38.705032+00:00"}
{"study_id": 196262, "supplement_id": 1477, "safety_score": "70", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to review the nature, chemical composition, biological properties, applications, and adverse effects of propolis, including its sensitizing potential and allergic reactions.", "results_summary": "The study found that propolis has antibacterial, antifungal, and antiviral properties, along with potential health benefits, but also noted risks such as contact allergy and allergic contact dermatitis.", "population_specificity": "Not specified (general review, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:39.652750+00:00"}
{"study_id": 196261, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of bee propolis on glycemic control, serum lipid profile, and insulin resistance indices in patients with type 2 diabetes.", "results_summary": "Propolis supplementation (900 mg/day) significantly improved fasting blood glucose and hemoglobin A1c levels, and showed a protective effect against increases in total cholesterol and LDL, but did not significantly affect other lipids or insulin resistance indices.", "population_specificity": "66 patients with type 2 diabetes.", "effective_dosage": "300 mg three times a day (total 900 mg/day).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:39.920906+00:00"}
{"study_id": 86734, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a 6-month personalized intensive dietary intervention emphasizing a prudent diet could enhance DNA repair activity (specifically base excision repair) in post-surgery colorectal cancer patients.", "results_summary": "The study found no significant change in BER activity in the intervention group compared to the control group, indicating that the dietary intervention did not affect DNA repair in these patients. A substantial range in inter- and intra-individual BER levels was observed.", "population_specificity": "Post-surgery colorectal cancer patients (stage I-III), enrolled 2-9 months after surgery.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:42.305158+00:00"}
{"study_id": 196263, "supplement_id": 1477, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of propolis (alone and in combination with zinc gluconate) in reducing halitosis when delivered via abrasive microcapsules in candy form.", "results_summary": "Breezy candy containing propolis (2%) and zinc gluconate (0.5%) reduced malodor by up to 60%, significantly outperforming traditional candy (10% reduction). The combination of abrasion and zinc supplementation showed the best potential for treating halitosis.", "population_specificity": "75 subjects with halitosis.", "effective_dosage": "Propolis 2% (alone) and propolis 1% (combined with zinc 0.25%) in abrasive microcapsules.", "study_duration": "Effects measured up to 4 hours (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:43.793549+00:00"}
{"study_id": 86733, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to examine associations between dietary patterns (including Prudent Diet) and changes in quality of life (QOL) in colorectal cancer (CRC) survivors over approximately one year post-diagnosis.", "results_summary": "The study found that the Western diet was associated with worse social functioning, while both dietary patterns (Western and Prudent) were linked to reported loss of appetite among CRC survivors. No specific efficacy of the Prudent Diet was highlighted in improving QOL.", "population_specificity": "Newly diagnosed colorectal cancer survivors (any stage) in the United States, predominantly female, non-Hispanic, White, with an average age of 56.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 6 and 12 months post-enrollment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:43.814787+00:00"}
{"study_id": 86735, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to describe the role of diet, food, and specific nutrients in the immune response related to HPV infection, progression to cervical cancer, and during oncological treatment.", "results_summary": "The study found that a prudent diet, similar to the Mediterranean diet, supports optimal immune function against HPV and cancer progression, and pre- and probiotics modulate microbiota favorably for preventive and therapeutic effects.", "population_specificity": "Individuals at risk of or affected by HPV infection and cervical cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:45.513989+00:00"}
{"study_id": 86736, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the association of the Prudent dietary pattern with serum metabolites and identify metabolic pathways linked to these metabolites, comparing it to the Western dietary pattern.", "results_summary": "The study found that the Prudent Diet was associated with distinct metabolite signatures, showing an inverse association with mitochondrial oxidative stress and lipid dysregulation, unlike the Western Diet. These findings suggest potential protective metabolic effects of the Prudent Diet against conditions like coronary artery disease and cancer.", "population_specificity": "2199 Women's Health Initiative participants (904 from the Observational Study and 1295 from the Hormone Therapy Trial).", "effective_dosage": "Not specified", "study_duration": "Cross-sectional (no specific intervention duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:47.416584+00:00"}
{"study_id": 86737, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic changes associated with a Prudent diet compared to a Western diet using targeted and nontargeted metabolite profiling.", "results_summary": "The study found increased concentrations of 3-methylhistidine and proline betaine in plasma and urine after participants followed a Prudent diet, suggesting distinct metabolic responses. Metabolite profiling revealed panels with distinctive trajectories linked to dietary patterns.", "population_specificity": "42 healthy participants from the Diet and Gene Intervention (DIGEST) pilot study.", "effective_dosage": "Not specified (complete diets provided, but exact quantities not detailed).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:47.883252+00:00"}
{"study_id": 86738, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the effects of a customized low-glycemic index, calorie-restricted diet versus standard care on glycemic index intake and its relationship with the rate of large-for-gestational-age infants in pregnant women.", "results_summary": "The customized intervention group showed a significant decrease in mean daily glycemic index and fewer large-for-gestational-age infants compared to the standard care group. The diet also led to lower birthweight and a notable reduction in glycemic index at dinner.", "population_specificity": "273 Italian women with a BMI \u226525 kg/m\u00b2, studied during weeks 9-12 of gestation.", "effective_dosage": "Not specified", "study_duration": "From the 9th-12th week of gestation until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:48.500196+00:00"}
{"study_id": 86739, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to summarize current perspectives on HDL functionality and how various dietary patterns, including Prudent Diet, affect cardiovascular health biomarkers.", "results_summary": "The study highlights that healthful dietary patterns like the Mediterranean and DASH diets, which are rich in plant-based foods, have beneficial effects on cardiovascular health, likely due to synergistic effects of dietary components. These diets may improve HDL functionality, including cholesterol efflux capacity and particle characteristics.", "population_specificity": "Not specified (general discussion of dietary patterns and cardiovascular health).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:48.533503+00:00"}
{"study_id": 86740, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of lifestyle interventions, including prudent diet, on diabetic neuropathy severity in type 2 diabetes outpatients.", "results_summary": "The study found that lifestyle interventions, including prudent diet, significantly reduced diabetic neuropathy severity in the intervention group compared to the control group (p<0.001). The control group showed no improvement or worsening symptoms.", "population_specificity": "74 patients with diabetic peripheral neuropathy (DPN) and type 2 diabetes.", "effective_dosage": "Not specified (part of broader lifestyle interventions).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:50.469570+00:00"}
{"study_id": 86743, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop evidence-based guidelines for preventing and treating malnutrition in cancer patients, including recommendations for adopting a prudent diet.", "results_summary": "The study found that malnutrition and muscle loss negatively impact cancer patients' outcomes and recommended nutritional interventions, including a prudent diet, alongside exercise training. However, pharmacological options for advanced cancer patients were noted to have limited effects.", "population_specificity": "Adult cancer patients, including those with advanced disease and cancer survivors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:52.830036+00:00"}
{"study_id": 86744, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a prudent diet combined with cholestyramine could reduce coronary atherosclerosis progression in men with familial hypercholesterolaemia (FH).", "results_summary": "The study found that the diet plus cholestyramine significantly reduced LDL cholesterol by 35% and slowed coronary atherosclerosis progression compared to usual care, with fewer patients showing progression and some showing regression.", "population_specificity": "26 men with familial hypercholesterolaemia (FH) and coronary artery disease (CAD).", "effective_dosage": "Cholestyramine 8 g twice daily (diet details not specified).", "study_duration": "39 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:53.719172+00:00"}
{"study_id": 86741, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the diagnostic value of urinary parameters in advanced chronic kidney disease (CKD) and provide dietary recommendations, including a Prudent Diet, for managing CKD.", "results_summary": "The study found that urinary parameters like volume, sodium, urea nitrogen, and phosphorus are useful for monitoring dietary habits and adherence to recommendations. It suggested specific urinary output and nutrient excretion targets (e.g., urinary Na <120 mEq/day, protein intake 48-72g/day) for CKD patients.", "population_specificity": "Patients with advanced chronic kidney disease (CKD), particularly those with GFR <25ml/min or <15ml/min.", "effective_dosage": "Protein intake 0.8-0.9g/kg/day, salt intake \u22645-6g/day, urinary phosphorus excretion <800mg/day (GFR<25ml/min) or <600mg/day (GFR<15ml/min).", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:55.092324+00:00"}
{"study_id": 86749, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of the Mediterranean diet (or \"prudent diet\") on cancer and cardiovascular disease risk in elderly populations.", "results_summary": "The study found that high adherence to a Mediterranean or prudent diet was associated with reduced risk of cardiovascular disease and some cancers in elderly individuals. Dietary interventions were also noted to potentially prevent morbidity, premature mortality, and improve quality of life in older persons.", "population_specificity": "Elderly individuals", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:55.990177+00:00"}
{"study_id": 86746, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of moderate red wine consumption combined with a \"Western prudent\" diet on blood parameters (lipid profile, antioxidant capacity, and erythrocyte membrane properties) in post-myocardial infarction patients.", "results_summary": "The study found that moderate red wine consumption (250 mL daily) alongside a \"Western prudent\" diet improved blood parameters, including reduced total cholesterol and LDL, increased erythrocyte membrane fluidity, and enhanced antioxidant status in post-myocardial infarction patients.", "population_specificity": "Post-myocardial infarction patients during a cardiac readaptation period.", "effective_dosage": "250 mL of red wine daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:56.128402+00:00"}
{"study_id": 86745, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the effects of dietary patterns, including the Prudent Diet, on chronic diseases such as obesity, type-2 diabetes, cardiovascular diseases, asthma, and neurodegenerative diseases.", "results_summary": "The study found that plant-based dietary patterns like the Prudent Diet, rich in fruits, vegetables, and whole grains, are effective in preventing various chronic diseases, while diets high in red and processed meat, refined grains, and added sugar increase disease risk. Evidence from both observational and clinical studies supports these findings.", "population_specificity": "General population (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:56.198469+00:00"}
{"study_id": 86747, "supplement_id": 1478, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of the Mediterranean diet and a prudent diet on TBARS levels in obese patients with OSAHS under CPAP treatment.", "results_summary": "The prudent diet led to a significant reduction in TBARS levels, similar to the Mediterranean diet, but showed less improvement in weight, BMI, waist circumference, and body fat percentage compared to the Mediterranean diet.", "population_specificity": "Obese patients with moderate to severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) under continuous positive airway pressure treatment.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:56.937211+00:00"}
{"study_id": 34264, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of autophagy in dysfunctional tumor endothelial cells and its impact on tumor vasculature and the tumor microenvironment, not specifically related to prunes.", "results_summary": "The study found that autophagy inhibition selectively prunes dysfunctional tumor vessels, improves vascular function, and optimizes the tumor immune microenvironment, enhancing the efficacy of chemotherapy and immunotherapy.", "population_specificity": "Tumor endothelial cells in clinical samples, zebrafish xenograft tumors, murine models, and human umbilical vein endothelial cells (HUVECs).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:58.753637+00:00"}
{"study_id": 34265, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify the relationship among the gut microbiome, immune responses, and bone protective effects of prunes on postmenopausal women.", "results_summary": "Responders to prune consumption (50-100 g daily) showed significantly lower levels of inflammatory markers (IL-1\u03b2 and TNF-\u03b1) and distinct gut microbiome profiles compared to non-responders, suggesting prunes may benefit bone mineral density in certain individuals.", "population_specificity": "Postmenopausal women with initial low bone mineral density (BMD).", "effective_dosage": "50-100 g prunes daily", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:00.832289+00:00"}
{"study_id": 34266, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of daily prune consumption (50 g or 100 g) on bone mineral density (BMD) and bone biomarkers in postmenopausal women over a 12-month period.", "results_summary": "The 50-g prune dose preserved total hip BMD (-0.3%) compared to a decrease in the control group (-1.1%) at 12 months, while the 100-g dose showed no significant difference. The pooled prune groups maintained hip fracture risk (FRAX) scores, unlike the control group, which worsened.", "population_specificity": "Postmenopausal women (mean age 62.1 \u00b1 5.0 years).", "effective_dosage": "50 g/day and 100 g/day.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:03.509489+00:00"}
{"study_id": 34267, "supplement_id": 1479, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of prunes as a dietary intervention to mitigate bone loss, particularly in osteopenic postmenopausal women, and to assess their anti-inflammatory and antioxidant effects.", "results_summary": "Preclinical studies showed prunes confer osteoprotective effects by preventing and reversing bone loss, with additional anti-inflammatory and antioxidant benefits. Clinical trials in postmenopausal women demonstrated promising effects on bone mineral density and biomarkers, though human data on oxidative stress and inflammation remain limited.", "population_specificity": "Osteopenic postmenopausal women and rodent models of osteopenia or osteoporosis.", "effective_dosage": "50-100 g/d", "study_duration": "6-12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:04.245092+00:00"}
{"study_id": 34273, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the chronic effects of CX546, an ampakine, on dendritic spine remodeling and synaptic efficacy in hippocampal slice cultures.", "results_summary": "Prolonged CX546 treatment reduced CA3-CA1 excitatory synapse and spine density but increased synaptic efficacy and structural plasticity, enhancing long-term potentiation (LTP) and cognitive function.", "population_specificity": "Organotypic hippocampal slice cultures (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:04.603180+00:00"}
{"study_id": 34268, "supplement_id": 1479, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine if daily consumption of 100 g of dried plum (prunes) positively influenced bone mineral density, bone strength, and bone biomarkers in men.", "results_summary": "The study found that daily consumption of 100 g of dried plum for 12 months led to significant decreases in bone resorption markers (TRAP5b and CTX) but no significant changes in bone mineral density at most sites. Modest bone-protective effects were observed, particularly in the proximal tibia.", "population_specificity": "66 adult men", "effective_dosage": "100 g dried plum daily", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:04.720246+00:00"}
{"study_id": 34272, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the effect of prunes on gastrointestinal (GI) function through a systematic review of randomized controlled trials (RCTs).", "results_summary": "Prunes improved stool frequency and consistency in constipated subjects compared to psyllium, and increased stool weight in non-constipated subjects, but no differences in GI symptoms were found. The evidence for non-constipated subjects was weak, and further rigorous research is needed.", "population_specificity": "Constipated and non-constipated subjects.", "effective_dosage": "100 g/day for constipated subjects.", "study_duration": "3 weeks for constipated subjects (duration for non-constipated subjects not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:05.072092+00:00"}
{"study_id": 34270, "supplement_id": 1479, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of prunes on stool output, whole gut transit time, gut microbiota, and short-chain fatty acids in healthy adults with low fiber intake and infrequent stool habits.", "results_summary": "Prunes significantly increased stool weight and frequency compared to the control group, with no significant changes in whole gut transit time or short-chain fatty acids. Flatulence incidence was higher with prune consumption, but no other adverse effects were noted.", "population_specificity": "Healthy adults with low fiber intake and stool frequency of 3-6 stools per week.", "effective_dosage": "80 g/day and 120 g/day, each with 300 ml/day water.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:05.539481+00:00"}
{"study_id": 34276, "supplement_id": 1479, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yoghurt containing prunes, along with GOS and linseed, could relieve constipation in elderly subjects.", "results_summary": "The test yoghurt with prunes increased defecation frequency, made defecation easier, and showed a tendency toward softer stools compared to the control yoghurt. Subjects also perceived the test yoghurt as more effective in relieving constipation.", "population_specificity": "Elderly subjects (mean age 76 years, range 61-92) with self-reported constipation (32 females, 11 males).", "effective_dosage": "12 g/day of prunes, combined with 12 g/day GOS and 6 g/day linseed, in 260 g/day yoghurt.", "study_duration": "3-week dietary intervention periods.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:08.170220+00:00"}
{"study_id": 34277, "supplement_id": 1479, "safety_score": "80", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of vapor-phase hydrogen peroxide (VPHP) in disinfecting prunes and its impact on microbial populations and prune quality.", "results_summary": "VPHP treatment reduced microbial populations to near zero after 10 minutes of exposure, but prolonged exposure (20 minutes or longer) caused oxidation damage to prune color. No hydrogen peroxide residues were detected 90 days post-treatment.", "population_specificity": "Dried prunes obtained from commercial dehydrators.", "effective_dosage": "Approximately 3.1 mg/l (wt/vol) of hydrogen peroxide.", "study_duration": "10 minutes (effective microbial reduction), 20 minutes or longer (oxidation damage observed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:11.241986+00:00"}
{"study_id": 196266, "supplement_id": 1479, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to characterize the effect of prune supplementation on the gut microbiome of postmenopausal women.", "results_summary": "The abstract does not provide specific results, but it suggests that prunes may have health benefits mediated by the gut microbiome in postmenopausal women.", "population_specificity": "Postmenopausal women ages 55-75", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:11.513198+00:00"}
{"study_id": 196264, "supplement_id": 1479, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of daily prune intake (50 g/d or 100 g/d) on cardiometabolic health markers, including glycemic control, blood lipids, and body composition, in postmenopausal women.", "results_summary": "Prune supplementation at 50 g/d or 100 g/d for 12 months did not significantly alter markers of glycemic control or blood lipids compared to the control group. However, the 100 g/d prune group showed a slight decrease in android total mass, suggesting a potential benefit in preventing adverse changes in central adiposity.", "population_specificity": "Postmenopausal women (mean age 62.1 \u00b1 4.9 years)", "effective_dosage": "50 g/d or 100 g/d", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:13.134660+00:00"}
{"study_id": 196265, "supplement_id": 1479, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of prune supplementation on immune, inflammatory, and oxidative stress markers in postmenopausal women to understand the mechanism behind prunes' bone-protective effects.", "results_summary": "Prune supplementation (50-100 g/day) reduced proinflammatory cytokine secretion from PBMCs and lowered circulating levels of activated monocytes, but did not affect hs-CRP, TAC, 8-isoprostane, or plasma cytokine concentrations.", "population_specificity": "Postmenopausal women aged 55-75 years.", "effective_dosage": "50 g/day and 100 g/day.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:13.155046+00:00"}
{"study_id": 33374, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of psilocybin therapy (PT) and escitalopram on behavioral and fMRI responses to musical surprises in patients with Major Depressive Disorder (MDD).", "results_summary": "PT showed a greater reduction in anhedonia compared to escitalopram and maintained subjective responses to musical surprises, while escitalopram reduced surprise-related affective responses. PT was associated with increased activation in sensory and prefrontal regions and reduced activation in the angular gyrus, suggesting different treatment mechanisms.", "population_specificity": "41 MDD patients with usable fMRI data (22 in PT group, 19 in escitalopram group).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:14.606488+00:00"}
{"study_id": 33373, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects of psilocybin, alone and in combination with eugenol, in an LPS-induced liver inflammation model in mice.", "results_summary": "Psilocybin significantly reduced pro-inflammatory cytokine levels, with the strongest effects observed for IL-1\u03b2, IL-6, and MCP-1. Its combination with eugenol also showed strong anti-inflammatory effects, particularly for COX-2 and TNF-\u03b1, while mitigating potential adverse effects of eugenol alone.", "population_specificity": "C57BL/6J mice with LPS-induced liver inflammation.", "effective_dosage": "0.88 mg/kg psilocybin (single dose).", "study_duration": "Not specified (acute intervention).", "interactions": "Combination with eugenol (17.59 mg/kg) was studied, but no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:14.965394+00:00"}
{"study_id": 33375, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate psilocybin's efficacy in reducing depressive and anxiety symptoms in cancer patients based on randomized controlled trials.", "results_summary": "Psilocybin significantly reduced depressive symptoms immediately post-administration, though effects were not sustained at 2 weeks. Anxiety symptoms showed substantial reductions both immediately and at 2-week follow-up, with the highest dose (0.3 mg/kg) being the most effective.", "population_specificity": "Cancer patients", "effective_dosage": "0.3 mg/kg (highest effective dose)", "study_duration": "Single administration with follow-up at day 1 and 2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:16.180745+00:00"}
{"study_id": 33377, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize evidence on the efficacy and safety of psilocybin-assisted therapy in reducing psychological and existential distress in cancer patients.", "results_summary": "Psilocybin therapy showed significant reductions in depression, anxiety, and existential distress, with sustained improvements over several months; adverse effects were generally mild and transient.", "population_specificity": "Patients with life-threatening cancer experiencing psychological and existential distress.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Several months (follow-up duration mentioned, but exact intervention length not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:19.410532+00:00"}
{"study_id": 33376, "supplement_id": 1480, "safety_score": "40", "efficacy_score": 62, "quality_score": 55, "study_goal": "The researchers aimed to systematically assess harm reporting, risk of bias, mechanism of action specification, and therapeutic effect sizes in psilocybin-for-depression randomized controlled trials (RCTs).", "results_summary": "Psilocybin demonstrated moderate superiority to controls in reducing depression (g = 0.62), though effects were heterogenous and attenuated in larger, better-controlled studies. Harm reporting and risk of bias were high, and mechanisms of action were rarely assessed.", "population_specificity": "602 participants (56% psilocybin) across 9 RCTs (10 subgroups) with depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:20.134509+00:00"}
{"study_id": 33378, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the effect of gene species variation on psilocybin and baeocystin production using exogenous genes from different psilocybin-producing mushrooms.", "results_summary": "The study found that psiD and psiK genes from P. cubensis performed best, while psiM genes from different species affected psilocybin and baeocystin production differently. The strain Gymdi30, with psiM from G. dilepis, achieved the highest psilocybin titer (1.46 g/L) reported to date.", "population_specificity": "Not applicable (in vitro study using E. coli strains).", "effective_dosage": "Not applicable (production titers measured in g/L).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:22.564276+00:00"}
{"study_id": 33379, "supplement_id": 1480, "safety_score": "65", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the optimal dosing of psilocybin for antidepressant-like effects while assessing its behavioral, physiological, and neurochemical impacts in rats.", "results_summary": "Psilocybin showed an inverted-U-shaped dose-response, with 0.32 mg/kg producing short- and long-term antidepressant-like effects without adverse effects, while higher doses (1.0 and 3.2 mg/kg) caused reduced body temperature, locomotor activity, and weight gain. BDNF levels increased dose-dependently but did not correlate with antidepressant-like behaviors.", "population_specificity": "Wistar rats", "effective_dosage": "0.1, 0.32, 1.0, and 3.2 mg/kg (single administration)", "study_duration": "Single administration with follow-up assessments", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:23.067316+00:00"}
{"study_id": 33382, "supplement_id": 1480, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to provide a comprehensive overview of psilocybin's therapeutic effects, safety profile, pharmacokinetics, and dosing guidelines.", "results_summary": "The review highlights psilocybin's therapeutic potential, efficacy, and safety, covering indications, contraindications, and adverse reactions while summarizing current pharmaceutical data.", "population_specificity": "Not specified (general review of existing data).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Drug-drug interactions mentioned, but specifics not provided.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:23.449713+00:00"}
{"study_id": 33381, "supplement_id": 1480, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the alignment of psilocybin clinical trial protocols for major depressive disorder (MDD) and treatment-resistant depression (TRD) with regulatory requirements.", "results_summary": "The study identified gaps in addressing drug interactions, concurrent antidepressant use, and prohibited medications in psilocybin trial protocols. Risk mitigation strategies were primarily based on external criteria, and certain regulatory aspects like functional unblinding or expectancy bias were not fully addressed.", "population_specificity": "Patients with major depressive disorder (MDD) and treatment-resistant depression (TRD), excluding those with bipolar spectrum disorders or schizoaffective disorders.", "effective_dosage": "25 mg (most commonly studied dose)", "study_duration": "Not specified", "interactions": "Potential drug interactions, acute and chronic concurrent use of antidepressants, and prohibited medications were noted as gaps.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:24.236791+00:00"}
{"study_id": 33380, "supplement_id": 1480, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety and efficacy of psilocybin for treating Substance Use Disorders (SUDs) through a systematic review of clinical trials and published studies.", "results_summary": "Psilocybin-assisted psychotherapy (PAP) showed significant reductions in alcohol consumption and smoking cessation, with neuroimaging data indicating normalized brain activity in AUD and high abstinence rates in TUD. Findings for other SUDs were mixed, though psilocybin demonstrated potential in reducing opioid dependence and nicotine use.", "population_specificity": "Individuals with Substance Use Disorders (SUDs), including Alcohol Use Disorder (AUD), Tobacco Use Disorder (TUD), Cocaine Use Disorder (CUD), Opioid Use Disorder, Nicotine Use Disorder, and multiple SUDs.", "effective_dosage": "Ranged from microdosing to 20-40 mg/70 kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:26.402019+00:00"}
{"study_id": 33383, "supplement_id": 1480, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the feasibility, safety, acceptability, and therapeutic effects of psilocybin-assisted psychotherapy for individuals with cancer-related prolonged grief disorder (PGD).", "results_summary": "The study is an open-label pilot trial assessing feasibility, safety, and participant-reported therapeutic effects, with outcomes to be evaluated over a 12-month follow-up period. No specific results are reported in the abstract, but the study includes qualitative and quantitative measures to assess therapeutic potential.", "population_specificity": "Approximately 15 people with cancer-related prolonged grief disorder (PGD).", "effective_dosage": "25 mg psilocybin (single psychoactive dose).", "study_duration": "5-week intervention period (including preparation and integration sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.964593+00:00"}
{"study_id": 33384, "supplement_id": 1480, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility and effects of psilocybin therapy in individuals with mild to moderate Parkinson's disease (PD) who also had depression and/or anxiety.", "results_summary": "The study found that psilocybin therapy was feasible and safe, with no serious adverse events or worsening of PD symptoms. Participants showed significant improvements in non-motor and motor symptoms, cognitive domains, and sustained reductions in depression and anxiety scores.", "population_specificity": "Individuals with mild to moderate Parkinson's disease (PD) plus depression and/or anxiety (mean age 63.2\u2009\u00b1\u20098.2 years, 5 women).", "effective_dosage": "One 10\u2009mg dose followed by one 25\u2009mg dose, administered with psychotherapy.", "study_duration": "The intervention lasted until the final safety assessment one month post-treatment, with some outcomes tracked for three months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.375298+00:00"}
{"study_id": 33386, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the medicinal potential of psilocybin, particularly in psychiatry and palliative care, by reviewing clinical trials.", "results_summary": "Psilocybin shows promise in treatment-resistant depression and palliative care, with a rapid onset of action linked to its 5HT2A receptor targeting, though its broader efficacy and role in psychotherapy remain unclear.", "population_specificity": "Adults in psychiatry and palliative care settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.836972+00:00"}
{"study_id": 33385, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a sustainable, biocatalytic method for producing psilocybin using immobilized enzymes, addressing the demand for pharmaceutical-grade material.", "results_summary": "The study demonstrated successful in vitro production of psilocybin from 4-hydroxy-l-tryptophan using a solid-phase matrix with covalently bound enzymes, achieving quantitative turnover. The method offers a reusable, selective, and scalable alternative to synthetic or in vivo production.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.837835+00:00"}
{"study_id": 33387, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to improve the de novo synthesis of psilocybin in E. coli by engineering PsiH variants and optimizing the biosynthetic pathway to enhance production yields.", "results_summary": "The study achieved a 100-fold improvement in psilocybin production (79.4 mg/L) by modifying PsiH variants, optimizing precursor supply, and enhancing fermentation conditions. Key intermediates like norbaeocystin also saw significant increases (105.3 mg/L).", "population_specificity": "Microbial cells (E. coli)", "effective_dosage": "Not applicable (in vitro production study)", "study_duration": "Not specified (flask fermentation optimization)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:32.531091+00:00"}
{"study_id": 33388, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to investigate the safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for treating fibromyalgia (FM) symptoms.", "results_summary": "The study found PAT was well-tolerated with transient side effects (elevated blood pressure, heart rate, and headaches). Participants reported clinically meaningful improvements in pain severity, pain interference, and sleep disturbance one month post-treatment.", "population_specificity": "Adults with fibromyalgia (N=5).", "effective_dosage": "Two oral doses (15 mg and 25 mg) administered two weeks apart.", "study_duration": "Intervention spanned approximately two weeks (dosing period), with follow-up assessments one month post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:33.389155+00:00"}
{"study_id": 33389, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether psilocybin could alleviate anxiety-like behaviors in juvenile SAPAP3-KO mice before they develop excessive self-grooming, and to examine its effects on synaptic proteins.", "results_summary": "Psilocybin treatment did not improve anxiety-like behaviors in juvenile SAPAP3-KO mice. Synaptic protein changes were observed in adult mice but not juveniles, suggesting age-dependent effects.", "population_specificity": "Juvenile SAPAP3-knockout (SAPAP3-KO) mice (10-13 weeks old), modeling obsessive-compulsive disorder (OCD).", "effective_dosage": "4.4 mg/kg (single dose).", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:35.972349+00:00"}
{"study_id": 33390, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 30, "study_goal": "The researchers aimed to explore the effects of psilocybin on brain complexity and behavior in a minimally conscious state patient, as a potential novel treatment for disorders of consciousness.", "results_summary": "The study found no significant increase in overt behavioral repertoire but observed new spontaneous behaviors and increased brain complexity (measured via EEG) in the patient.", "population_specificity": "A single patient in a minimally conscious state plus (post-comatose disorder of consciousness).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:36.446690+00:00"}
{"study_id": 33393, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 45, "study_goal": "The researchers aimed to investigate the perceived effects of psilocybin on neuropsychiatric symptoms in individuals with long COVID by analyzing self-reported online accounts.", "results_summary": "The study found that 78.2% of posts reported improvement in long COVID symptoms after psilocybin use, with 77.9% of these improvements lasting beyond the acute psychedelic experience. However, 11.8% reported worsening symptoms.", "population_specificity": "Individuals with self-reported long COVID and neuropsychiatric symptoms who used psilocybin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:39.745096+00:00"}
{"study_id": 33391, "supplement_id": 1480, "safety_score": "70", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a single dose of psilocybin combined with brief psychotherapy could reduce relapse rates and alcohol use in patients with alcohol use disorder (AUD) following withdrawal treatment.", "results_summary": "The study found no significant differences between psilocybin and placebo groups in abstinence duration or mean alcohol use at 4-week and 6-month follow-ups. Both groups reported reduced craving, with an additional reduction observed in the psilocybin group, but adverse events were more frequent in the psilocybin group.", "population_specificity": "Adults with AUD who completed withdrawal treatment within six weeks prior to enrollment.", "effective_dosage": "Single oral dose of 25 mg psilocybin.", "study_duration": "4-week follow-up (with additional 6-month data mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:39.981379+00:00"}
{"study_id": 33392, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of psilocybin-assisted psychotherapy on depression, anxiety, and suicidality symptoms between participants who discontinued antidepressants and those who were unmedicated at screening.", "results_summary": "Both groups showed clinically significant improvements in depression, anxiety, and suicidality symptoms, with no significant differences between them. The intensity of the psychedelic experience was also similar across groups.", "population_specificity": "27 participants with treatment-resistant depression, divided into those who discontinued antidepressants (n=18) and those unmedicated at screening (n=9).", "effective_dosage": "Single 25 mg oral dose of psilocybin.", "study_duration": "Follow-up assessments up to 2 months post-dose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:40.037227+00:00"}
{"study_id": 33394, "supplement_id": 1480, "safety_score": "65", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and risk stratification of psilocybin therapy for individuals with a family history of bipolar disorder (BD).", "results_summary": "The study reviewed existing evidence and proposed a risk stratification tool to evaluate the relative risks of psilocybin therapy for individuals with a family history of BD, advocating for cautious but not outright exclusion in clinical trials.", "population_specificity": "Individuals with a family history of bipolar disorder (BD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:40.454689+00:00"}
{"study_id": 33395, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to develop and refine guidelines for ethical and supportive facilitator use of touch during psilocybin-assisted therapy retreats to enhance participant safety and therapeutic experience.", "results_summary": "The study iterated initial touch guidelines based on unexpected experiences, focusing on maintaining safety, therapeutic boundaries, and empathetic responses during psilocybin sessions. The revised guidelines aimed to reinforce participant safety and support their subjective experience.", "population_specificity": "Participants in group retreat-based psilocybin-assisted therapy (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:42.208341+00:00"}
{"study_id": 33398, "supplement_id": 1480, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight potential prolonged adverse effects of psilocybin use in psychedelic therapy training programs and the conflicts between psychiatric and psychedelic community practices.", "results_summary": "The study reported a case of severe prolonged adverse effects (sleep impairment, anhedonia, suicidal ideation) following repeated high-dose psilocybin use in training, resolved only after ECT. It underscores tensions between legal/underground psychedelic use and psychiatric interventions.", "population_specificity": "A psychologist undergoing psychedelic therapy training.", "effective_dosage": "Repeated high doses of psilocybin-containing mushrooms (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:45.239659+00:00"}
{"study_id": 33396, "supplement_id": 1480, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of COMP360 psilocybin (25 mg, 10 mg, and 1 mg doses) in participants with treatment-resistant depression over a 52-week observational follow-up period.", "results_summary": "A single 25 mg dose of psilocybin demonstrated a longer maintenance of antidepressant effect compared to 10 mg and 1 mg doses, with few adverse events reported. The 25 mg group had a median time to depressive event of 92 days, significantly longer than the 10 mg (83 days) and 1 mg (62 days) groups.", "population_specificity": "Participants with treatment-resistant depression from previous studies (COMP 001 and COMP 003).", "effective_dosage": "25 mg, 10 mg, and 1 mg (single administration).", "study_duration": "52-week observational follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:46.452118+00:00"}
{"study_id": 33400, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether psilocybin could mitigate cognitive, motor, and behavioral deficits caused by repetitive mild head injuries by reducing neuroinflammation and enhancing neuroplasticity.", "results_summary": "Psilocybin reduced vasogenic edema, restored vascular reactivity and functional connectivity, decreased phosphorylated tau buildup, increased brain-derived neurotrophic factor (BDNF) and TrkB levels, and modulated lipid signaling molecules in a rat model of repetitive mild head injury.", "population_specificity": "Adult female rats with induced repetitive mild head injuries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:47.993290+00:00"}
{"study_id": 33399, "supplement_id": 1480, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "To investigate the pharmacokinetics, feasibility, safety, and efficacy of a single-dose psilocybin therapy in adults with severe alcohol use disorder (AUD).", "results_summary": "A single 25 mg psilocybin dose significantly reduced alcohol consumption, heavy drinking days, and craving while increasing self-efficacy over 12 weeks, despite notable pharmacokinetic variations.", "population_specificity": "10 treatment-seeking adults (8 men, 2 women; median age 44) with severe AUD.", "effective_dosage": "25 mg (single dose).", "study_duration": "12 weeks post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:48.493204+00:00"}
{"study_id": 33401, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 75, "quality_score": 60, "study_goal": "To evaluate the effect of psilocybin-assisted psychotherapy on a Parkinson's disease patient with dispositional pessimism and difficulty accepting her diagnosis.", "results_summary": "Psilocybin-assisted psychotherapy improved the patient's pessimistic outlook, reduced anxious ruminations, and enhanced well-being without affecting motor status. The treatment was well-tolerated and facilitated acceptance of pharmacological adjustments.", "population_specificity": "A 43-year-old female with Parkinson's disease and no depression but difficulty adjusting to her diagnosis.", "effective_dosage": "High-dose (specific amount not stated), four sessions within one year.", "study_duration": "One year (four sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:48.569594+00:00"}
{"study_id": 33402, "supplement_id": 1480, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the physiological effects, contraindications, and safety considerations of psilocybin and other psychedelics in the context of anesthesia and perioperative care.", "results_summary": "The study highlights that psilocybin activates serotonin receptors, causing sympathetic nervous system activation and potential hemodynamic instability, with risks of serotonin syndrome. Chronic use may affect cortisol levels, impacting preoperative glucocorticoid dosing.", "population_specificity": "Not specified (general review of psychedelic effects, likely including both clinical and non-clinical populations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Serotonin syndrome risk with other serotonergic drugs, potential interaction with glucocorticoids, and historical reports of LSD potentiating opioids and MAO inhibition.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:49.506603+00:00"}
{"study_id": 33403, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the level of information and attitudes toward psilocybin-assisted therapy (PAT) among mental health experts, patients, and the general population.", "results_summary": "Higher knowledge scores, self-assessed knowledge, personal treatment experience, and psychedelic experience predicted more positive attitudes toward PAT. Balanced information (including risks) increased acceptance.", "population_specificity": "Mental health experts, patients, and the general population (1,456 participants).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:49.845117+00:00"}
{"study_id": 33404, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize existing research on psilocybin's behavioral effects and explore its potential efficacy and mechanisms for treating PTSD-related symptoms.", "results_summary": "Psilocybin demonstrated promising antidepressant and anxiolytic effects in preclinical and clinical studies, suggesting potential for alleviating PTSD symptoms, though challenges and drawbacks for therapeutic use were noted.", "population_specificity": "Individuals with PTSD or related symptoms (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:52.925732+00:00"}
{"study_id": 33372, "supplement_id": 1480, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the latest research on psilocybin's pharmacokinetics, pharmacodynamics, clinical efficacy, and safety profile for treating psychiatric and neurological disorders.", "results_summary": "Emerging evidence supports psilocybin's efficacy in treating major depressive disorder, treatment-resistant depression, anxiety, alcohol use disorders, and cancer-related distress, though methodological and regulatory barriers remain. Advances in biosynthetic production and psychotherapeutic integration are needed for scalability and accessibility.", "population_specificity": "Patients with psychiatric and neurological disorders (e.g., MDD, TRD, anxiety, AUD, cancer-related distress).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:54.475302+00:00"}
{"study_id": 33406, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of low-moderate psilocybin doses (10 mg) on cognitive flexibility and neuroplasticity in individuals with OCD, while assessing its feasibility as a clinical treatment.", "results_summary": "The study protocol outlines a blinded dosing design (1 mg and 10 mg) with therapeutic support, measuring cognitive flexibility (ID-ED task) and neuroplasticity (EEG vLTP task), but results are not yet reported. Secondary outcomes include OCD symptom severity and subjective experiences.", "population_specificity": "20 participants with obsessive-compulsive disorder (OCD).", "effective_dosage": "1 mg (active placebo) and 10 mg (low-moderate dose), administered once each, four weeks apart.", "study_duration": "12 weeks (including preparation, dosing sessions, and follow-up).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:56.563641+00:00"}
{"study_id": 33408, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of psilocybin on anxiety- and depressive-like behaviors in serotonin transporter knockout (KO) mice compared to wild-type (WT) mice.", "results_summary": "Psilocybin-induced head-twitch and hyperlocomotor responses were absent in KO mice, and it blocked weight loss in female WT mice. Psilocybin did not significantly alter anxiety- or depression-like behaviors in either genotype, though a trend was observed in WT females. Female KO mice exhibited anhedonia-like behavior.", "population_specificity": "Serotonin transporter knockout (KO) and wild-type (WT) mice, with noted sex-specific effects.", "effective_dosage": "1 mg/kg (single dose).", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:57.878390+00:00"}
{"study_id": 33407, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the feasibility of using diffusion MRI to characterize microstructural brain differences following psilocybin treatment in mice and identify potential neural substrates for its antidepressant effects.", "results_summary": "Psilocybin induced microstructural changes in the brain, including increased mean diffusivity in the primary visual cortex at 24h and in the striatum and hippocampus at 72h, along with structural connectivity differences in the frontal association cortex at 72h. These findings suggest psilocybin affects neural microstructure and connectivity, potentially underlying its rapid antidepressant effects.", "population_specificity": "11-15 week-old C57BL/6J male mice", "effective_dosage": "Not specified", "study_duration": "Effects assessed at 24h and 72h post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:57.986285+00:00"}
{"study_id": 33411, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess and improve the psychotherapeutic protocol components of Psilocybin-assisted therapy (PAT) for cancer-related demoralization and chronic pain.", "results_summary": "The study identified critical incidents, wish list items, and contributing factors to improve PAT protocols, emphasizing the importance of tailoring therapy to patients' medical history and needs, supporting common factors, and ensuring collaborative care. Recommendations across nine topic areas were derived from the data.", "population_specificity": "Patients with cancer-related demoralization and chronic pain, along with their caregivers and licensed mental health clinicians.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:58.411067+00:00"}
{"study_id": 33410, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility, tolerability, and preliminary efficacy of a single 25 mg dose of psilocybin combined with massed cognitive processing therapy (CPT) for treating chronic PTSD.", "results_summary": "The study will assess feasibility and tolerability as primary outcomes, with secondary objectives focusing on preliminary efficacy in reducing PTSD severity and exploring mechanisms of change. Results are pending as the study is ongoing.", "population_specificity": "Fifteen participants with chronic PTSD.", "effective_dosage": "Single 25 mg dose of psilocybin.", "study_duration": "7 days (including 12 CPT sessions, two psilocybin-related psychotherapy sessions, and one psilocybin dosing session).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:58.475686+00:00"}
{"study_id": 33413, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize recent data on psilocybin's safety, efficacy, delivery, subjective effects, pharmacology, and neurobiological effects for treating depression and other mental health disorders.", "results_summary": "The abstract indicates psilocybin therapy shows promise for treating depression and other mental health disorders, with recent data supporting its efficacy and outlining its pharmacology and neurobiological effects. Other psychedelic substances with therapeutic potential are also briefly discussed.", "population_specificity": "Not specified (general mental health disorders, particularly depression).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:00.990312+00:00"}
{"study_id": 33414, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize human studies on psilocybin's effects on blood-based biomarkers of major depressive disorder (MDD) to guide future clinical research.", "results_summary": "Psilocybin administration consistently decreased interleukin-6, C-reactive protein, and eosinophils, while increasing cortisol, prolactin, oxytocin, thyroid-stimulating hormone, adrenocorticotropic hormone, brain-derived neurotrophic factor, and free fatty acids. Effects on other biomarkers like interleukin-1\u03b2 and tumor necrosis factor-alpha were less consistent.", "population_specificity": "Healthy participants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:02.541024+00:00"}
{"study_id": 33417, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether psilocybin could alleviate behavioral despair and cognitive deficits induced by chronic stress in a rodent model, focusing on its interaction with the HPA axis and ECS.", "results_summary": "Psilocybin significantly reduced stress-induced behavioral despair and cognitive impairments, likely through ECS-mediated downregulation of the HPA axis, suggesting sustained therapeutic benefits for stress-related disorders.", "population_specificity": "Male Wistar rats exposed to chronic stress via predator odor and social instability.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:05.632058+00:00"}
{"study_id": 33415, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate factors moderating the acute and long-term effects of psilocybin-assisted therapy on depression, anxiety, PTSD, and personality traits, including demographic factors and subjective experiences.", "results_summary": "A single high dose of psilocybin combined with therapy reduced symptoms of anxiety, depression, PTSD, and neuroticism over 3 months, while increasing openness and conscientiousness. Subjective experiences like mystical-type experiences, emotional breakthrough, and personal growth, along with demographic factors, moderated these positive changes.", "population_specificity": "Participants in a psilocybin-assisted therapy program (specific demographics not detailed in the abstract).", "effective_dosage": "Single high dose (exact amount not specified).", "study_duration": "3 months (follow-up period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:06.910223+00:00"}
{"study_id": 33416, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the long-term effects of psilocybin therapy (PT) with escitalopram treatment (ET) in patients with moderate-to-severe major depressive disorder (MDD).", "results_summary": "Both PT and ET showed sustained improvements in depressive symptom severity at 6 months, with PT demonstrating greater improvements in psychosocial functioning, psychological connectedness, and meaning in life compared to ET.", "population_specificity": "Patients aged 18-80 with moderate-to-severe MDD (HAM-D \u226517), no MRI or SSRI contraindications, and confirmed diagnosis by a healthcare professional.", "effective_dosage": "Two 25 mg doses of psilocybin administered orally with psychological support.", "study_duration": "6 weeks (with 6-month follow-up).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:07.193403+00:00"}
{"study_id": 33409, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to quantify the acute effects of psilocybin on executive functions and attention, examining moderators like dosage, timing, and task characteristics.", "results_summary": "Psilocybin increased reaction times (indicating impaired executive functions) but did not significantly affect accuracy; effects on reaction time were dose-dependent and moderated by task sensitivity to executive functions.", "population_specificity": "Not specified (meta-analysis of empirical studies)", "effective_dosage": "Not specified (effects were dose-dependent but exact dosages not detailed)", "study_duration": "Acute phase (90-180 minutes post-administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:07.450707+00:00"}
{"study_id": 33418, "supplement_id": 1480, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the optimal dose and timing of psilocybin for treating Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD) through a meta-analysis of randomized controlled trials.", "results_summary": "Psilocybin significantly reduced depressive symptoms compared to placebo at Day 8 and Day 15, with a 25 mg dose being the most effective. However, it was associated with a higher risk of adverse events, particularly nausea.", "population_specificity": "Adult patients with Major Depressive Disorder (MDD).", "effective_dosage": "25 mg, 0.215 mg/kg, and 10 mg.", "study_duration": "Efficacy was evaluated at Days 2, 8, and 15 post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:07.647713+00:00"}
{"study_id": 33419, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether psilocybin-assisted therapy (PAT) could attenuate personality abnormalities in patients with alcohol use disorder (AUD) and whether reductions in trait impulsiveness were associated with lower alcohol consumption.", "results_summary": "The psilocybin group showed significant reductions in neuroticism and increases in extraversion and openness compared to placebo, with decreases in impulsiveness linked to lower posttreatment alcohol consumption, particularly among those with prior moderate- or high-risk drinking.", "population_specificity": "Adults with alcohol use disorder (AUD) (N=84).", "effective_dosage": "Two medication sessions (psilocybin or diphenhydramine), exact dosage not specified.", "study_duration": "12 weeks of psychotherapy plus 24 weeks of follow-up (total 36 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:08.276071+00:00"}
{"study_id": 33420, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of psilocybin in patients with severely treatment-resistant depression (TRD).", "results_summary": "Psilocybin significantly reduced depressive symptoms at 3 and 12 weeks post-treatment, with the Oceanic Boundlessness dimension correlating with antidepressant responses. Patients with comorbid PTSD showed less antidepressant effect.", "population_specificity": "Adults aged 18-65 with severe TRD (insufficient benefit from at least five prior treatments).", "effective_dosage": "25 mg (single dose).", "study_duration": "12 weeks (follow-up).", "interactions": "Psychotropic medications were discontinued 2 weeks prior to dosing through 3 weeks post-dosing.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:10.720807+00:00"}
{"study_id": 33421, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence base for psilocybin with psychological support/therapy (PST) in treating psychiatric disorders and provide recommendations for future research.", "results_summary": "The study found the most developed evidence for psilocybin in treating major depressive disorder (MDD), with positive signals in three double-blind RCTs, but noted limitations like small samples, unsuccessful blinding, and variability in dosing. Overall, the evidence was deemed insufficient to recommend psilocybin with PST as a psychiatric treatment.", "population_specificity": "Patients with obsessive-compulsive and related disorders, anxiety/depression linked to cancer, MDD, substance use disorders, anorexia, and demoralization in AIDS survivors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:12.648909+00:00"}
{"study_id": 33423, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the neurobiological mechanisms underlying the therapeutic effects of psilocybin-assisted psychotherapy (PAP) in treating eating disorders (EDs).", "results_summary": "The study suggests emerging evidence for the safety and efficacy of PAP in improving treatment outcomes for EDs but highlights limited knowledge of its neurobiological mechanisms. It reviews methodologies like MRI and molecular neuroimaging to probe these mechanisms.", "population_specificity": "Individuals with eating disorders (EDs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:14.774233+00:00"}
{"study_id": 33422, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to develop a structured psychological support framework (CPSM) to enhance the safety and meaningfulness of psilocybin experiences in clinical trials for treatment-resistant depression.", "results_summary": "The study introduced the Compass Psychological Support Model (CPSM) to provide psychological support during psilocybin treatment, emphasizing therapist training and fidelity assessment to ensure consistent delivery. The framework aims to optimize the therapeutic potential of psilocybin for mental health conditions.", "population_specificity": "Individuals with treatment-resistant depression participating in Compass-sponsored clinical trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:15.124128+00:00"}
{"study_id": 33425, "supplement_id": 1480, "safety_score": "75", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility and safety of psilocybin-assisted psychotherapy (PAT) for treating methamphetamine (MA) dependence.", "results_summary": "The study found that PAT following inpatient withdrawal management led to significant cognitive and emotional shifts, sustained MA abstinence, and improved mental health, self-esteem, mindfulness, and distress tolerance in a daily MA user.", "population_specificity": "A 36-year-old transwoman and daily MA user.", "effective_dosage": "Not specified", "study_duration": "One session of psilocybin-assisted therapy, with follow-up over 3 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:15.396595+00:00"}
{"study_id": 33426, "supplement_id": 1480, "safety_score": "30", "efficacy_score": 20, "quality_score": 40, "study_goal": "The researchers aimed to evaluate psilocybin's potential as a disease-modifying therapy for ALS, focusing on its mechanisms and safety.", "results_summary": "The study found no pre-clinical ALS models, case reports, or trials supporting psilocybin's efficacy in slowing ALS progression, and highlighted risks of psychological side effects like hallucinations.", "population_specificity": "Not specified (general ALS context).", "effective_dosage": "Not specified (dosing mentioned as variable but not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:15.682063+00:00"}
{"study_id": 33424, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of sex and peri-acute negative experiences (stress) in the acute and post-acute mood-altering effects of psilocybin.", "results_summary": "Psilocybin increased head-twitch response frequency more in female mice than males. It induced anxiolytic-like effects, which were fully blocked by stress in males but only partially in females. Stress and psilocybin independently increased corticosterone levels without additive effects.", "population_specificity": "Adult male and female C57BL/6J mice", "effective_dosage": "5 mg/kg (intraperitoneal)", "study_duration": "Acute administration with behavioral assessments starting 24 hours post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:16.201291+00:00"}
{"study_id": 33428, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the enduring effects of psilocybin-assisted therapy on empathy in depressed patients using a randomized, placebo-controlled design.", "results_summary": "Patients who received psilocybin showed significant improvements in explicit emotional empathy, particularly towards positive stimuli, compared to the placebo group for at least two weeks. The study suggests psilocybin may enhance social cognition in individuals with depression.", "population_specificity": "Fifty-one depressed patients.", "effective_dosage": "0.215 mg/kg body weight (single dose).", "study_duration": "4-week psychological support intervention with follow-up measurements at 2 days, 1 week, and 2 weeks post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:19.111068+00:00"}
{"study_id": 33429, "supplement_id": 1480, "safety_score": "75", "efficacy_score": null, "quality_score": 80, "study_goal": "The researchers aimed to collate and evaluate adverse event data from psilocybin-assisted psychotherapy clinical trials, focusing on definition, measurement, and reporting methods.", "results_summary": "The review found that psilocybin-assisted psychotherapy was generally safe, with common adverse events including elevated blood pressure, headaches, nausea, and anxiety. Suicidal ideation and behavior were rare and mainly observed in participants with a history of such tendencies.", "population_specificity": "Clinical populations, particularly those with treatment-resistant depression.", "effective_dosage": "Heterogeneous doses (specific amounts not detailed in the abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:21.521490+00:00"}
{"study_id": 33430, "supplement_id": 1480, "safety_score": "40", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to highlight potential adverse events of psilocybin and underline the limitations of quantitative methodology in clinical trials for treatment-resistant depression.", "results_summary": "The study found that psilocybin could temporarily worsen suicidal ideation and cause prolonged adverse events, yet paradoxically, participants reported functional improvements not captured by rating scales. The case demonstrated mixed outcomes, with both destabilization and perceived personal benefits.", "population_specificity": "A participant in a phase 2b clinical trial for treatment-resistant depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.400013+00:00"}
{"study_id": 33427, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine the relationships between psilocybin dose, psychedelic experiences, and therapeutic outcome in treatment-resistant depression.", "results_summary": "The intensity of psychedelic effects was dose-related, with depression response correlating with specific aspects of the psychedelic experience. At the 25 mg dose, certain dimensions of the psychedelic experience showed the strongest correlation to improved depression scores at Week 3.", "population_specificity": "233 participants with treatment-resistant depression", "effective_dosage": "Single doses of 25, 10, or 1 mg of COMP360 psilocybin", "study_duration": "Single administration with follow-up at 3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.525916+00:00"}
{"study_id": 33434, "supplement_id": 1480, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the antidepressant effects of psilocybin-assisted therapy (PAT) versus comparator treatments in major depressive disorder (MDD), including treatment-resistant depression.", "results_summary": "Psilocybin-assisted therapy showed superior antidepressant effects compared to control interventions, with medium to large effect sizes sustained for up to 6 weeks. Adverse effects, though increased, were generally mild (e.g., headache, dizziness).", "population_specificity": "Patients with major depressive disorder (MDD), including treatment-resistant depression.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Effects were assessed up to 6 weeks post-intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:24.334129+00:00"}
{"study_id": 33435, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of psilocybin as an anti-nociceptive agent in preclinical animal models and its translational potential for chronic pain patients.", "results_summary": "The study found that psilocybin shows promise in reducing chronic pain through serotonergic pathways and neuroplastic actions, improving functional connectivity in brain regions involved in pain, but further research is needed.", "population_specificity": "Preclinical animal models (neuropathic and inflammatory pain) and potential chronic pain patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:24.907241+00:00"}
{"study_id": 33433, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the efficacy and long-term effects of psilocybin in treating mental disorders, focusing on depression, substance use disorders, and anxiety.", "results_summary": "Psilocybin demonstrated strong efficacy against depression (including treatment-resistant cases) with effect sizes (Cohen's d) ranging from 0.67 to 2.6. It also showed promise for alcohol use disorders and anxiety in life-threatening illnesses like cancer.", "population_specificity": "Patients with depression, substance use disorders (particularly alcohol), and anxiety related to life-threatening somatic illnesses (e.g., cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:25.319975+00:00"}
{"study_id": 33432, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether psilocybin therapy could improve symptoms of depression, burnout, and PTSD in clinicians who developed these conditions from frontline work during the COVID-19 pandemic.", "results_summary": "Psilocybin therapy resulted in a significant reduction in depression symptoms compared to niacin, with a mean difference of -12.00 on the MADRS scale. While improvements in burnout and PTSD symptoms were numerically larger in the psilocybin group, these changes did not reach statistical significance.", "population_specificity": "Physicians, advanced practice practitioners (APPs), and nurses who provided frontline care during the pandemic and had moderate or severe depression symptoms but no prepandemic mental health diagnoses.", "effective_dosage": "25 mg psilocybin orally in a single medication session.", "study_duration": "The intervention included 2 preparation visits, 1 medication session, and 3 integration visits, with outcomes measured at day 28 post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:26.543428+00:00"}
{"study_id": 33436, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore psilocybin's potential as a therapeutic agent for mental health, including its use in clinical trials for severe psychiatric conditions and low-dose applications for general well-being.", "results_summary": "The study highlights psilocybin's versatility in treating depression and anxiety through personalized dosing and its integration into wellness products, suggesting it could reshape mental health treatment paradigms.", "population_specificity": "Not specified (abstract mentions various contexts but no specific population).", "effective_dosage": "Not specified (mentions personalized dosing and low-dose applications but no exact amounts).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:27.419023+00:00"}
{"study_id": 33437, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the legal and ethical considerations surrounding psilocybin as a potential treatment for psychiatric illnesses.", "results_summary": "The abstract highlights psilocybin's promising potential for treating psychiatric conditions but notes unresolved legal and ethical issues, including regulation, access, and provider-patient dynamics.", "population_specificity": "Not specified (general discussion of psychiatric illnesses).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:29.319484+00:00"}
{"study_id": 33440, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate psilocybin's chemical properties, mechanisms of action, and therapeutic potential in psychiatric treatment, while proposing future research directions.", "results_summary": "The study highlights psilocybin's high therapeutic potential in psychiatry, supported by clinical evidence, and notes its safety in trials with manageable side effects, though additional safety measures are recommended.", "population_specificity": "Not specified (general psychiatric applications discussed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:30.922165+00:00"}
{"study_id": 33438, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety, feasibility, and therapeutic efficacy of psilocybin-assisted therapy (PAT) for depression and anxiety, particularly in patients with life-threatening diseases.", "results_summary": "PAT showed significant immediate and partially sustained improvements in depressive and anxious symptomatology, with comparable efficacy to selective serotonergic reuptake inhibitors in one study. The therapy was found safe and feasible in clinical models, though larger, more diverse studies are needed for stronger conclusions.", "population_specificity": "General population with depressive symptoms and patients with somatic life-threatening diseases experiencing depression and anxiety.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:31.808687+00:00"}
{"study_id": 33441, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess patient attitudes toward participating in a trial examining psilocybin for chronic neuropathic pain and identify factors influencing willingness to participate.", "results_summary": "Most participants (76.9%) were willing to join the trial, with prior psychedelic use being higher among \"willing\" participants. Motivations included the need for new treatments and personal pain management benefits, while discouraging factors were practical difficulties and potential adverse events.", "population_specificity": "26 patients with chronic neuropathic pain", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.757505+00:00"}
{"study_id": 33442, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the impact of psilocybin on sleep quality and its relationship with depressive symptom improvements.", "results_summary": "The study found that psilocybin significantly reduced both depressive symptoms and sleep disturbances, though sleep improvements were smaller. Baseline sleep disturbances were linked to lower depression remission rates, suggesting a potential interaction between sleep and psilocybin's efficacy.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.962193+00:00"}
{"study_id": 33443, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess psychiatrists' knowledge and attitudes toward psilocybin therapy in Ireland to understand its potential impact on clinical practice and public health.", "results_summary": "Most psychiatrists (81.5%) agreed psilocybin therapy shows promise for psychiatric disorders, with 86.8% supporting research funding and willingness to refer patients if licensed. However, 21.9% thought it potentially addictive, and only 9.9% felt prepared to participate in therapy.", "population_specificity": "Psychiatrists in Ireland (151 participants, 73.3% under 40, 76.0% trainees, 49.0% female).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:34.616299+00:00"}
{"study_id": 33445, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a sustainable production process for psilocybin using engineered fungal strains to meet future therapeutic demands.", "results_summary": "The study demonstrated a fivefold increase in psilocybin production in Saccharomyces cerevisiae and a 10-fold increase in Aspergillus nidulans through genetic modifications and process optimization, achieving a final titre of 267 mg/L.", "population_specificity": "Engineered fungal strains (Saccharomyces cerevisiae and Aspergillus nidulans).", "effective_dosage": "Not specified for human consumption.", "study_duration": "Not specified for human trials.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:36.008120+00:00"}
{"study_id": 33446, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of psilocybin in treating depression compared to established psychotherapy alone.", "results_summary": "The study found a large and clinically significant reduction in depressive symptoms with psilocybin compared to baseline and placebo, with sustained effects over time.", "population_specificity": "Patients with depression", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:36.431343+00:00"}
{"study_id": 33444, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of acute psilocybin administration on compulsive-like behaviors in SAPAP3 knockout mice, a model for obsessive-compulsive and related disorders.", "results_summary": "Acute psilocybin administration led to enduring reductions in compulsive behavior in male SAPAP3 KO mice and reduced grooming behavior in female WT and SAPAP3 KO mice, with effects lasting up to 1 week post-injection. Psilocybin increased locomotion in WT mice but not in KO mice, while the hallucinogenic-like head-twitch response was observed in both genotypes.", "population_specificity": "Male and female SAPAP3 knockout (KO) mice and wild-type (WT) littermates.", "effective_dosage": "1 mg/kg, intraperitoneal (single dose).", "study_duration": "Effects assessed at 1, 3, and 8 days post-injection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:36.824990+00:00"}
{"study_id": 33447, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze the structure and function of PsiK, an enzyme involved in psilocybin biosynthesis, to support future bioengineering efforts for enhanced therapeutic properties.", "results_summary": "The study provided crystallographic and mutagenesis insights into PsiK's substrate recognition, which will aid in bioengineering psilocybin variants with improved therapeutic potential.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:38.851352+00:00"}
{"study_id": 33450, "supplement_id": 1480, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight the risks of psilocybin use in individuals with predisposing factors for psychosis, based on a case report and review of similar cases.", "results_summary": "The study found that psilocybin can induce psychotic episodes, particularly in individuals with predisposing risk factors (e.g., depression, personality disorder traits, cannabis use) who consume high or repeated doses. This reinforces concerns about psilocybin's safety in vulnerable populations.", "population_specificity": "Individuals with predisposing risk factors for psychosis (e.g., history of depression, personality disorder traits, cannabis use).", "effective_dosage": "Heavy psilocybin use (specific dosage not provided).", "study_duration": "Several months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.269644+00:00"}
{"study_id": 33449, "supplement_id": 1480, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether discontinuation of antidepressant drugs affects the efficacy and subjective psychedelic experience of psilocybin treatment in individuals with treatment-resistant depression.", "results_summary": "The study found that antidepressant discontinuation did not worsen depression severity before baseline, and psilocybin treatment efficacy and subjective psychedelic effects were not compromised by prior antidepressant use. The results support psilocybin as a feasible monotherapy for treatment-resistant depression.", "population_specificity": "233 participants with treatment-resistant depression (TRD).", "effective_dosage": "25 mg, 10 mg, or 1 mg of COMP360 psilocybin (single administration).", "study_duration": "Primary endpoint measured at Week 3 post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.703263+00:00"}
{"study_id": 33451, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to discuss psilocybin's impact on glutamatergic neurotransmission and its therapeutic potential for depression and other nervous system disorders.", "results_summary": "Psilocybin acts as a 5-HT2A receptor agonist, increasing glutamate release in the frontal cortex and hippocampus, which enhances GABAergic interneuron activity and may promote antidepressant effects. It also appears to influence neuroplasticity via the glutamatergic pathway.", "population_specificity": "Not specified (clinical and preclinical studies referenced).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.855015+00:00"}
{"study_id": 33448, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility and preliminary efficacy of psilocybin-assisted frontal-midline theta neurofeedback for improving executive functions.", "results_summary": "The study found no task-based improvements in executive functions but reported significant self-reported gains in daily executive functions (working memory, shifting, monitoring, and inhibition) with medium to high effect sizes. The experimental group also showed significant gains in their key training goals, indicating external relevance.", "population_specificity": "Thirty-seven eligible participants with executive function deficits, randomized into an experimental group (n = 18) and a passive control group (n = 19).", "effective_dosage": "Three microdose sessions followed by three psilocybin-assisted neurofeedback sessions (specific dosage not detailed).", "study_duration": "Duration of intervention not explicitly stated, but involved six sessions (three microdose and three neurofeedback).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:43.406536+00:00"}
{"study_id": 33455, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to identify concerns and facilitating factors regarding the acceptability and access to psilocybin-assisted therapy among palliative care professionals.", "results_summary": "Palliative care professionals expressed interest in psilocybin-assisted therapy but highlighted concerns such as training needs, legalization, research gaps, and protocol refinement. Acceptability and access expansion were found to be interrelated.", "population_specificity": "16 palliative care professionals", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:44.548825+00:00"}
{"study_id": 33454, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the protective effects of psilocybin in cellular and animal models of stroke.", "results_summary": "Psilocybin reduced glutamate-mediated neuronal loss in rat cortical cultures and reduced brain infarction and neurological deficits in stroke rats. It also improved locomotor behavior and regulated BDNF expression, with these effects being attenuated by the BDNF inhibitor ANA12.", "population_specificity": "Adult male and timed-pregnant Sprague-Dawley rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:44.746193+00:00"}
{"study_id": 33453, "supplement_id": 1480, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of psilocybin in reducing excessive self-grooming and anxiety behaviors in SAPAP3 KO mice, a model for OCD-like symptoms.", "results_summary": "Psilocybin and psychedelic mushroom extract significantly reduced self-grooming behaviors, head-body twitches, and anxiety in SAPAP3 KO mice, with effects persisting up to 7 weeks in responders. The mushroom extract showed superior effects on secondary outcomes compared to pure psilocybin.", "population_specificity": "SAPAP3 KO mice (28 male, 22 female) exhibiting OCD-like behaviors.", "effective_dosage": "4.4 mg/kg, single intraperitoneal injection.", "study_duration": "21-day observation period, with some effects tracked up to 7 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:45.865546+00:00"}
{"study_id": 33456, "supplement_id": 1480, "safety_score": "75", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness, safety, and tolerability of psilocybin in treating major depressive disorder (MDD) in adults through a systematic review of randomized controlled trials.", "results_summary": "Psilocybin showed beneficial effects on depressive symptoms in 60% of the included studies and significantly improved anxiety symptoms in 80% of the studies assessing this outcome. Discontinuation rates and adverse drug reactions were similar between psilocybin and control groups, with headache being the most common adverse reaction.", "population_specificity": "Physically healthy adult patients with major depressive disorder (MDD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:48.218800+00:00"}
{"study_id": 33458, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore psilocybin as a potential treatment option for PTSD by examining its neurobiological mechanisms and pharmacodynamic principles.", "results_summary": "The abstract suggests psilocybin may be an underexplored treatment for PTSD, but further research is required to confirm its efficacy and safety.", "population_specificity": "Patients with posttraumatic stress disorder (PTSD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:49.803992+00:00"}
{"study_id": 33457, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of subjective effects and dissociation in mediating psilocybin-induced therapeutic outcomes for depression and substance use disorder (SUD).", "results_summary": "The study found a greater mediating effect of subjective symptoms for psilocybin compared to ketamine, particularly in depression, with an R2-value of 24%. Psilocybin showed stronger therapeutic mediation in SUD than in depression.", "population_specificity": "Patients with depression or substance use disorder (SUD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:50.122646+00:00"}
{"study_id": 33459, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate psilocybin's potential neuroprotective and neuroplastic effects as a prophylactic therapeutic against Parkinson's disease (PD).", "results_summary": "Psilocybin may promote neuron repair via 5-HT2A receptor activation, increasing BDNF release and reducing \u03b1-synuclein accumulation, suggesting potential benefits for PD prevention.", "population_specificity": "Cell and animal models (not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:50.478417+00:00"}
{"study_id": 33461, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the information processing mechanisms affected by psilocybin, particularly its effects on belief updating and optimism bias in a behavioral task.", "results_summary": "Psilocybin increased task engagement and reward achievement in rats by modifying forgetting rates and reducing loss aversion, suggesting an optimism bias through altered belief updating.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:52.232380+00:00"}
{"study_id": 33460, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate psilocybin's effects on cognitive function and its potential benefits and risks in psychiatric disorders.", "results_summary": "Psilocybin showed mixed effects on cognitive function, with no significant changes in global cognition or processing speed in healthy individuals but improvements in sustained attention, working memory, and executive function in treatment-resistant depression (TRD) patients. Emotional processing and empathy were positively modified, while cognitive flexibility and creative cognition initially declined but potentially improved over time.", "population_specificity": "Healthy volunteers (85% of studies) and patients with treatment-resistant depression (TRD).", "effective_dosage": "Macrodoses ranging from 45 \u03bcg/kg to 30 mg/70 kg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:52.974046+00:00"}
{"study_id": 33462, "supplement_id": 1480, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and safety of psilocybin in Veterans with severe treatment-resistant depression (TRD).", "results_summary": "At 3 weeks posttreatment, 60% of participants met response criteria and 53% met remission criteria; at 12 weeks, 47% maintained response and 40% remission. No unexpected adverse events occurred, and the psychedelic experience did not correlate with depression changes.", "population_specificity": "Veterans with severe treatment-resistant depression (TRD), some with comorbid PTSD.", "effective_dosage": "25 mg of psilocybin (single dose).", "study_duration": "Follow-up assessments at 3 and 12 weeks posttreatment.", "interactions": "Participants on antidepressants were tapered to avoid drug interactions.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:54.094593+00:00"}
{"study_id": 33464, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore novel lysergic acid derivatives and innovative dosing methods for psilocybin, as well as its potential in treating binge eating disorder and enhancing emotional responses.", "results_summary": "The study highlights advancements in psychedelic research, including modified LSD-like actions and personalized dosing strategies based on ABCF1 gene expression, suggesting therapeutic potential for mental health treatment.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:55.559685+00:00"}
{"study_id": 33463, "supplement_id": 1480, "safety_score": "85", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to assess the safety, tolerability, and effects of low-dose oral psilocybin with psychological support on headache severity, frequency, and cognition in patients with chronic SUNHA.", "results_summary": "No significant adverse events were recorded, but cognitive function could not be assessed due to high subjective dose intensity. Limited effects on headache duration and severity were observed, though two participants showed a >50% reduction in daily attack frequency.", "population_specificity": "Four patients with chronic SUNHA (three completers).", "effective_dosage": "Ascending doses of 5, 7.5, and 10 mg (one dose per session; three dosing sessions total).", "study_duration": "Three dosing sessions (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:56.030888+00:00"}
{"study_id": 33465, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 40, "study_goal": "The researchers aimed to evaluate psilocybin's potential as a treatment for Complex Regional Pain Syndrome (CRPS) in a patient with refractory symptoms.", "results_summary": "The study found that psilocybin provided significant pain relief and functional improvement in the patient, suggesting its potential efficacy for chronic pain management.", "population_specificity": "A single patient with refractory CRPS.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:57.498829+00:00"}
{"study_id": 33466, "supplement_id": 1480, "safety_score": "90", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to assess the safety and efficacy of psilocybin-assisted therapy (PAT) for alleviating existential distress in a patient with stage 4 astrocytoma.", "results_summary": "The patient responded positively to PAT without adverse events, and the therapy partially alleviated existential distress. The study highlights the need for expanded access to PAT, especially for patients with brain cancer.", "population_specificity": "A single patient with end-of-life distress secondary to stage 4 astrocytoma.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:58.185108+00:00"}
{"study_id": 33467, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize and identify knowledge gaps concerning the pharmacokinetic characteristics of psilocybin and its active metabolite, psilocin.", "results_summary": "Psilocybin is rapidly converted to psilocin, which reaches peak plasma and brain levels dose-dependently, with a half-life of 2-3 hours. The review identified gaps in pharmacokinetic data and study limitations that could guide future research.", "population_specificity": "Animals and humans (no specific demographic details provided).", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:58.903658+00:00"}
{"study_id": 33471, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the association between different psychological protocols and the efficacy of psilocybin-assisted therapy for depressive symptoms.", "results_summary": "The study found that psilocybin-assisted therapy significantly improved depressive symptoms, with a pooled standard mean difference of 10.08, but the improvement was not associated with the type of psychological protocol used.", "population_specificity": "515 adult patients with clinically diagnosed depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:01.571407+00:00"}
{"study_id": 33469, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic effects of single-dose and two-dose psilocybin administration on depressive symptom severity in patients with MDD or TRD.", "results_summary": "Psilocybin significantly reduced depressive symptoms in patients with MDD or TRD, with two-dose administration sometimes producing more pronounced and lasting effects, though the exact reason for this difference remains unclear.", "population_specificity": "Patients with a primary diagnosis of major depressive disorder (MDD) or treatment-resistant depression (TRD).", "effective_dosage": "Single-dose and two-dose psilocybin treatments (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:01.747450+00:00"}
{"study_id": 33468, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether psilocybin enhances extinction following cocaine self-administration and attenuates cue-induced drug-seeking in mice and rats.", "results_summary": "Psilocybin had no effect on cocaine-seeking behavior in both male and female mice and rats, as significant cue-induced reinstatement was observed regardless of treatment. The study suggests psilocybin is ineffective under the tested conditions.", "population_specificity": "Male and female mice (16 female, 19 male) and rats (24 female, 23 male).", "effective_dosage": "Mice: 1.0 mg/kg psilocybin; Rats: 1.0 mg/kg or 2.5 mg/kg psilocybin.", "study_duration": "Mice: 8 days of cocaine self-administration and extinction training; Rats: 15 days of cocaine self-administration and extinction training.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:03.277518+00:00"}
{"study_id": 196268, "supplement_id": 1480, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to test whether psilocybin-producing species of Inocybaceae are monophyletic and to explore the evolutionary history of muscarine and psilocybin in these fungi.", "results_summary": "The study found that psilocybin production evolved independently in at least two lineages of Inocybaceae, with transitions occurring after muscarine loss. Muscarine was not ancestral for the family but represents a conserved trait in some clades.", "population_specificity": "Inocybaceae fungi, primarily from tropical and southern hemisphere temperate regions.", "effective_dosage": "Not available", "study_duration": "Not applicable (evolutionary study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:04.734604+00:00"}
{"study_id": 33971, "supplement_id": 1481, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether the resurgence of psychedelics in mental health treatment represents a true paradigm shift or an integration into existing therapeutic frameworks.", "results_summary": "The study found that while psychedelics offer rapid therapeutic effects and unique mechanisms, they should be viewed as enhancements to existing psychiatric models rather than a complete paradigm shift, cautioning against overestimating their revolutionary potential.", "population_specificity": "Not specified (general discussion of psychedelic therapy in psychiatry)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:05.359945+00:00"}
{"study_id": 33972, "supplement_id": 1481, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess psychedelic practitioners' viewpoints on psychological support strategies for psychedelic treatments, comparing emotive and neuromodulatory approaches.", "results_summary": "The study found no consensus on psychological support strategies but identified an aggregate preference for an emotive approach, particularly among practitioners trained at MAPS or CIIS. Four latent factors were identified, including trust, spirituality, emotional setting, and conceptualizing negative experiences.", "population_specificity": "Psychedelic practitioners in research settings (42.5% MD/DO, 57.5% other) from at least 4 countries, 11 U.S. states, and 16 institutions.", "effective_dosage": "Not specified", "study_duration": "Data collected from March 2023 to July 2023 (intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:07.357244+00:00"}
{"study_id": 33979, "supplement_id": 1481, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the historical development, therapeutic applications, and potential treatment effects of psychedelic therapy, particularly in depression, trauma disorders, and substance use disorders.", "results_summary": "The study highlights that psychedelics, especially psilocybin, show promising potential in treating neuropsychiatric diseases like treatment-resistant depression and substance addictions, with significant effects reported in psychotherapy-assisted applications for cancer-related anxiety and depression.", "population_specificity": "Patients with life-threatening cancer-related anxiety and depression, treatment-resistant depression, and substance use disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:07.443844+00:00"}
{"study_id": 33977, "supplement_id": 1481, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the subjective effects of LSD and psilocybin between patients undergoing psychedelic-assisted therapy (PAT) and healthy volunteers, and to investigate the relationship between antidepressant effects and acute drug effects in patients.", "results_summary": "Ratings of overall drug effect and mystical experience were similar across groups, but patients reported lower ego dissolution. PAT significantly reduced depressive symptoms, with relaxation during sessions being the strongest predictor of antidepressant outcomes, while mystical experiences showed no relationship with efficacy. Most adverse effects were mild and resolved within 48 hours.", "population_specificity": "28 PAT patients with depressive symptoms and 28 healthy volunteers.", "effective_dosage": "Varying doses of psilocybin and LSD (specific amounts not provided).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:07.516541+00:00"}
{"study_id": 33980, "supplement_id": 1481, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate existing approaches to integrating psychotherapy with psychedelic administration and provide recommendations for optimizing therapeutic benefits.", "results_summary": "The systematic review highlights the lack of consensus on integrating psychedelic experiences with evidence-based psychotherapy and offers clear recommendations for improving therapeutic outcomes and scientific inference.", "population_specificity": "Not specified (broad focus on psychiatric disorders).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.444661+00:00"}
{"study_id": 35797, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of sage oil in mitigating obesity-induced testicular apoptosis, oxidative stress, and reduced spermatogenesis in male rats.", "results_summary": "Sage oil supplementation normalized body weight, reduced testicular oxidative stress and apoptosis, and improved sperm count and germ cell proliferation in obese rats.", "population_specificity": "Dietary-induced obese male rats", "effective_dosage": "0.05 ml/kg body weight", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:15.707741+00:00"}
{"study_id": 35795, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify predictors of patient satisfaction in outpatient health services in China using data from the WHO SAGE survey.", "results_summary": "The study found that self-reported treatment outcomes and patient-rated communication were the strongest predictors of satisfaction, with logistic regression and random forests predicting satisfaction with 74% accuracy. Dissatisfaction was rare (1.8%).", "population_specificity": "Adult populations in China, particularly those utilizing outpatient health services.", "effective_dosage": "Not available", "study_duration": "Not applicable (survey-based study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.042992+00:00"}
{"study_id": 35799, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine whether anticoagulation satisfaction differs among atrial fibrillation (AF) patients with and without physical, cognitive, and psychosocial conditions.", "results_summary": "The study found that visual impairment, depressive symptoms, and anxiety were significantly associated with high perceived anticoagulation burden. Different conditions were linked to high burden in warfarin versus direct oral anticoagulant (DOAC) users.", "population_specificity": "AF patients aged 65 years or older prescribed oral anticoagulants (warfarin or DOACs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.333905+00:00"}
{"study_id": 35800, "supplement_id": 1533, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the efficacy and safety of SAGE-217, an oral GABA type A receptor modulator, in treating major depressive disorder.", "results_summary": "SAGE-217 significantly reduced depressive symptoms compared to placebo at day 15, with a mean HAM-D score reduction of -17.4 vs. -10.3. Adverse events like headache and dizziness were more common in the SAGE-217 group, but no serious adverse events were reported.", "population_specificity": "Patients with major depressive disorder.", "effective_dosage": "30 mg once daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.518250+00:00"}
{"study_id": 35793, "supplement_id": 1533, "safety_score": "40", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a rapid method for quantifying terpenes and terpenoids in Sage essential oil and assess their variation in commercial samples and degradation under ozone treatment.", "results_summary": "The study found significant variation in terpene and terpenoid content among commercial Sage oils, with some samples dominated by toxic thujones and others containing none. Ozone treatment degraded sabinene and \u03b2-pinene but left \u03b1/\u03b2-thujone more resistant.", "population_specificity": "Commercial Sage essential oils and fresh Sage leaves.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.584458+00:00"}
{"study_id": 35798, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers sought to assess geriatric impairments in patients with atrial fibrillation and determine if these impairments influenced oral anticoagulant prescribing.", "results_summary": "Geriatric impairments (e.g., cognitive impairment, frailty) were common in the cohort, but oral anticoagulant prescribing did not vary by impairment status, suggesting prescribers may overlook these factors.", "population_specificity": "Patients aged 65+ with atrial fibrillation, CHA2DS2-VASc score \u22652, and no contraindications to oral anticoagulants (n = 1244).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.597954+00:00"}
{"study_id": 35796, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the physiological responses and stress acclimatization of two sage cultivars ('Icterina' and 'Purpurascens') under chilling conditions (4 \u00b0C) versus control (18 \u00b0C).", "results_summary": "Chilling induced dynamic changes in enzyme activity (APX, GPX) and antioxidant capacity in 'Purpurascens,' while 'Icterina' showed more stable responses. 'Purpurascens' exhibited increased phenolic content and antioxidant capacity under stress, whereas chilling reduced dry matter content in both cultivars.", "population_specificity": "Two sage cultivars ('Icterina' and 'Purpurascens')", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.496113+00:00"}
{"study_id": 35794, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the survival status of older adults (50+ years) who were HIV-negative, HIV-positive not on ART, and HIV-positive on ART in Uganda.", "results_summary": "The study found that older adults living with HIV on ART had nearly twice the mortality risk compared to HIV-negative adults, while those not on ART had the highest risk. The adjusted hazard ratio for mortality was 1.75 (ART group) and 2.09 (non-ART group) compared to HIV-negative participants.", "population_specificity": "Older adults (50+ years) in rural and peri-urban Uganda, including HIV-negative and HIV-positive individuals.", "effective_dosage": "Not mentioned", "study_duration": "Data collected across three waves (2009, 2012-2013, 2015-2016).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:18.032744+00:00"}
{"study_id": 35801, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of sage extract, both alone and in combination with enterocin M, on rabbit growth, feed conversion, microbial activity, and fermentation.", "results_summary": "Sage extract reduced propionic and butyric acid levels while increasing concentrations of other fatty acids and lactic acid. It also showed a prolonged reduction effect on amylolytic activity and improved enzymatic activities in the caecum.", "population_specificity": "Rabbits (weaned and older animals)", "effective_dosage": "10 \u03bcL/animal/day in water", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.062642+00:00"}
{"study_id": 35804, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to test the effectiveness of the SAGE intervention in promoting physical activity and fruit and vegetable consumption among young children in early care and education centers.", "results_summary": "The study designed a garden-based curriculum to engage children in healthy lifestyle activities, but specific efficacy results are not detailed in the abstract. The intervention included active learning, dietary observation, and parent engagement components.", "population_specificity": "Children aged 3-5 years in early care and education centers (20 sites).", "effective_dosage": "Not specified", "study_duration": "12 sessions", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.471602+00:00"}
{"study_id": 35803, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the physicochemical and functional properties of poly(\u03b5-caprolactone) films containing sage extract for potential use in active food packaging to prevent oxidation and microbial growth.", "results_summary": "The study found that sage extract incorporation into PCL films provided strong antioxidant and antimicrobial activity against Staphylococcus aureus and Escherichia coli, while minimally affecting tensile properties and thermal stability. Water vapor and aroma permeability increased with sage extract addition.", "population_specificity": "Not applicable (in vitro study on film properties)", "effective_dosage": "5%, 10%, and 20% loading contents of sage extract in PCL films", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.747493+00:00"}
{"study_id": 35802, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of the SAGE hybrid model in improving knee image segmentation by reducing interobserver error and user intervention.", "results_summary": "SAGE achieved high interobserver Dice Similarity Coefficients (DSCs) in both healthy and osteoarthritic (OA) knee segmentation, with consistent performance across femoral, tibial, and patellar cartilage. It also demonstrated improved efficiency with reduced user input time.", "population_specificity": "Knee images from healthy individuals and those with osteoarthritis (OA).", "effective_dosage": "Not applicable (methodological study).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.801358+00:00"}
{"study_id": 35805, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate predictors of hypertension prevalence and management in South Africa, including traditional risk factors and sociodemographic indicators.", "results_summary": "The study found that 43% of adults were hypertensive, with low awareness (58% unaware) and control (18% controlled on medication). Waist-to-height ratio > 0.5 and diabetes comorbidity were significant predictors of hypertension presence, awareness, and treatment.", "population_specificity": "Adults in South Africa (n=1847; 68% female; median age 51 years).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.956368+00:00"}
{"study_id": 35806, "supplement_id": 1533, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the anti-inflammatory effect of the flavonoid fraction of Lepechinia meyenii (Sage) on leukocytes from patients with rheumatoid arthritis.", "results_summary": "The flavonoid fraction LM8 reduced superoxide anion production in neutrophils and decreased the expression of pro-inflammatory genes (TNF\u03b1, IL8, IL17) in mononuclear leukocytes from RA patients. The effects were concentration-dependent, with LM8 showing the best immunomodulating effect among tested fractions.", "population_specificity": "Patients with rheumatoid arthritis.", "effective_dosage": "60, 120, and 180 \u00b5g/mL for neutrophils; 120 \u00b5g/mL for mononuclear leukocytes.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:27.293928+00:00"}
